https://www.pharmaceutical-technology.com/news/astronautx-wins-48m-in-funding-for-developing-therapies/ 2023-10-09T16:49:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alnylam-abandons-plans-for-rnai-drug-onpattro-after-fda-hits-the-brakes/ 2023-10-09T14:49:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-expands-cosentyx-reach-for-rheumatic-diseases-with-iv-version-approval/ 2023-10-09T13:41:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/limmatech-raises-37m-for-antimicrobial-resistance-research/ 2023-10-10T03:43:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/islet-transplantation-for-type-1-diabetes-do-regulators-have-it-right/ 2023-10-09T10:03:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-zhifei-shingles-vaccine-china/ 2023-10-09T10:20:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/semaglutide-price-comparison-us-europe/ 2023-11-03T12:55:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-acquires-horizon-therapeutics/ 2023-10-09T10:17:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-ema-nsclc-combo-therapy/ 2023-10-09T08:36:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-to-buy-mirati/ 2023-10-09T08:31:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biologics-are-poised-to-overtake-innovative-small-molecules/ 2023-10-06T17:12:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/t2d-ckd-glp-agonists-treatments/ 2023-10-06T16:37:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ocular-launches-ocular-implant-trial-to-combat-macular-degeneration/ 2023-10-06T16:32:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emergex-and-vic-to-develop-infectious-disease-therapies-in-the-gulf/ 2023-10-06T14:36:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-panel-says-amgens-phase-iii-lung-cancer-kras-drug-data-is-unreliable/ 2023-10-06T13:42:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/thermo-fisher-expands-us-manufacturing-plant-to-support-biologics/ 2023-10-11T09:12:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/serum-institute-of-india-plans-to-increase-global-reach/ 2023-10-06T12:45:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/treat-california-embarks-on-plan-to-earn-5bn-for-psychedelic-research/ 2023-10-06T12:43:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/twist-bioscience-bayer-antibody-discovery/ 2023-10-06T10:20:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-mitokinin-acquisition/ 2023-10-06T10:16:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-divest-stake-haleon/ 2023-10-06T08:46:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agomab-fscd-therapy-fast-track-designation/ 2023-10-06T07:09:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/adcs-huge-licensing-growth-continues/ 2023-10-05T17:01:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lumicell-co-founder-wins-nobel-prize-in-chemistry/ 2023-10-05T15:17:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japanese-kyowa-kirin-acquires-orchard-to-bolster-gene-therapy-pipeline/ 2023-10-11T09:13:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazenecas-forxiga-meets-primary-endpoint-for-t2d/ 2023-10-05T11:36:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-endorses-calliditas-alport-syndrome-drug-for-orphan-designation/ 2023-10-05T11:33:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inhibikases-risvodetinib-wins-fda-orphan-drug-designation/ 2023-10-05T10:09:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/advanz-licence-dmx-200/ 2023-10-05T10:05:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shorla-funds-oncology-drug-candidates/ 2023-10-05T10:02:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-launches-national-full-body-scan-platform-to-accelerate-drug-discovery/ 2023-10-05T09:34:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-draft-guidance/ 2023-10-05T08:07:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/imidomics-wuxi-antibody-development-imids/ 2023-10-05T08:05:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/strides-pharma-gets-fda-greenlight-to-market-hiv-treatment/ 2023-10-04T18:14:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizers-hospira-issues-recall-after-glass-particles-found-in-injectables/ 2023-10-04T17:39:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-continues-expansion-spree-by-licencing-tevas-ibd-drug-for-1-5bn/ 2023-10-04T17:37:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-split-complete-as-sandoz-begins-trading-on-swiss-exchange/ 2023-10-16T23:49:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ey-report-finds-cracks-in-pharma-supply-chain-operations/ 2023-10-04T14:50:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fluoguide-imaging-agent-wins-fda-orphan-drug-designation-for-glioma-surgery/ 2023-10-04T14:56:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-intellia-crispr-based-therapies/ 2023-10-11T09:13:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-eua-novavax-vaccine/ 2023-10-04T10:05:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-point-biopharma/ 2023-10-04T08:11:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-sage-takeda-dengue-vaccine/ 2023-10-04T08:06:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ocu-410st-ocugen-juvenile-macular-degeneration-stargardt-disease-likelihood-of-approval/ 2025-01-19T16:38:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neu-411-neuron23-parkinson-s-disease-likelihood-of-approval/ 2025-01-19T16:38:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/epinephrine-bitartrate-de-motu-cordis-anaphylaxis-likelihood-of-approval/ 2023-10-04T03:51:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vilamakitug-xbiotech-metastatic-adenocarcinoma-of-the-pancreas-likelihood-of-approval/ 2023-10-04T03:51:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/jtt-861-japan-tobacco-systolic-heart-failure-likelihood-of-approval/ 2023-10-04T03:25:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hp-518-hinova-pharmaceuticals-metastatic-castration-resistant-prostate-cancer-mcrpc-likelihood-of-approval/ 2024-09-09T01:36:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/stp-707-sirnaomics-ovarian-cancer-likelihood-of-approval/ 2025-01-19T16:38:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ntx-001-neuraptive-therapeutics-peripheral-nerve-injury-likelihood-of-approval/ 2023-10-04T03:44:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/edg-7500-edgewise-therapeutics-hypertrophic-cardiomyopathy-likelihood-of-approval/ 2024-07-05T01:23:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bay-2416964-bayer-colorectal-cancer-likelihood-of-approval/ 2024-06-14T01:18:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bay-2416964-bayer-pancreatic-cancer-likelihood-of-approval/ 2024-06-14T01:18:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bay-2416964-bayer-breast-cancer-likelihood-of-approval/ 2024-06-14T01:18:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aur-106-aurigene-oncology-transitional-cell-cancer-urothelial-cell-cancer-likelihood-of-approval/ 2024-07-05T06:27:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aur-106-aurigene-oncology-ureter-cancer-likelihood-of-approval/ 2024-07-05T06:27:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aur-106-aurigene-oncology-kidney-cancer-renal-cell-cancer-likelihood-of-approval/ 2024-07-05T06:27:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aur-106-aurigene-oncology-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-07-05T06:27:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aur-106-aurigene-oncology-esophageal-cancer-likelihood-of-approval/ 2024-07-05T06:27:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aur-106-aurigene-oncology-colon-cancer-likelihood-of-approval/ 2024-07-05T06:27:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aur-106-aurigene-oncology-gastric-cancer-likelihood-of-approval/ 2024-07-05T06:27:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aur-106-aurigene-oncology-bladder-cancer-likelihood-of-approval/ 2024-07-05T06:27:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gi-301-yuhan-atopic-dermatitis-atopic-eczema-likelihood-of-approval/ 2025-01-19T16:38:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wsd-0922-wayshine-biopharma-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-19T16:38:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wsd-0922-wayshine-biopharma-anaplastic-astrocytoma-likelihood-of-approval/ 2025-01-19T16:38:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wsd-0922-wayshine-biopharma-glioblastoma-multiforme-gbm-likelihood-of-approval/ 2025-01-19T16:38:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wsd-0922-wayshine-biopharma-metastatic-brain-tumor-likelihood-of-approval/ 2025-01-19T16:38:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iks-03-iksuda-therapeutics-b-cell-non-hodgkin-lymphoma-likelihood-of-approval/ 2024-09-09T01:36:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iks-03-iksuda-therapeutics-follicular-lymphoma-likelihood-of-approval/ 2024-09-09T01:36:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iks-03-iksuda-therapeutics-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2024-09-09T01:35:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iks-03-iksuda-therapeutics-mantle-cell-lymphoma-likelihood-of-approval/ 2024-09-09T01:36:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/il2-cd25-bristol-myers-squibb-chronic-cutaneous-lupus-erythematosus-ccle-discoid-lupus-erythematosus-dle-likelihood-of-approval/ 2025-01-19T16:38:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/measles-rubella-vaccine-indian-immunologicals-rubella-german-measles-likelihood-of-approval/ 2025-01-19T16:38:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/il2-cd25-bristol-myers-squibb-subacute-cutaneous-lupus-erythematosus-scle-likelihood-of-approval/ 2025-01-19T16:38:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/slate-001-gritstone-bio-pancreatic-ductal-adenocarcinoma-likelihood-of-approval/ 2025-01-19T16:38:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/il2-cd25-bristol-myers-squibb-systemic-lupus-erythematosus-likelihood-of-approval/ 2025-01-19T16:38:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ds-3939-glycotope-metastatic-ovarian-cancer-likelihood-of-approval/ 2024-07-05T01:22:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ds-3939-glycotope-metastatic-transitional-urothelial-tract-cancer-likelihood-of-approval/ 2024-07-05T01:22:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ds-3939-glycotope-metastatic-biliary-tract-cancer-likelihood-of-approval/ 2024-07-05T01:22:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ds-3939-glycotope-metastatic-breast-cancer-likelihood-of-approval/ 2024-07-05T01:22:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ds-3939-glycotope-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-07-05T01:22:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ds-3939-glycotope-pancreatic-ductal-adenocarcinoma-likelihood-of-approval/ 2024-07-05T01:22:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/datopotamab-deruxtecan-daiichi-sankyo-metastatic-biliary-tract-cancer-likelihood-of-approval/ 2025-01-19T16:37:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/datopotamab-deruxtecan-daiichi-sankyo-bladder-cancer-likelihood-of-approval/ 2025-01-19T16:37:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dengue-vaccine-indian-immunologicals-dengue-fever-likelihood-of-approval/ 2025-01-19T16:37:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tcp-25-in2cure-epidermolysis-bullosa-likelihood-of-approval/ 2025-01-19T16:37:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tcp-25-in2cure-leg-ulcers-likelihood-of-approval/ 2025-01-19T16:37:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azercabtagene-zapreleucel-imugene-non-hodgkin-lymphoma-likelihood-of-approval/ 2025-01-19T16:37:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azercabtagene-zapreleucel-imugene-b-cell-acute-lymphocytic-leukemia-b-cell-acute-lymphoblastic-leukaemia-likelihood-of-approval/ 2025-01-19T16:37:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/renaparin-corline-biomedical-delayed-graft-function-dgf-likelihood-of-approval/ 2025-01-19T16:37:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tmp-301-tempero-bio-substance-drug-abuse-likelihood-of-approval/ 2025-01-19T16:37:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/infigratinib-phosphate-qed-therapeutics-achondroplasia-likelihood-of-approval/ 2025-01-19T16:37:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/resomelagon-synact-pharma-rheumatoid-arthritis-likelihood-of-approval/ 2025-01-19T16:37:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/maveropepimut-s-imv-peritoneal-cancer-likelihood-of-approval-2/ 2023-10-04T01:46:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/maveropepimut-s-imv-peritoneal-cancer-likelihood-of-approval/ 2024-05-20T01:27:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/maveropepimut-s-imv-fallopian-tube-cancer-likelihood-of-approval/ 2024-05-20T01:27:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teriparatide-la-shenzhen-salubris-pharmaceuticals-net-present-value/ 2024-12-13T02:51:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nn-9932-novo-nordisk-net-present-value/ 2024-07-02T02:04:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lomedeucitinib-bristol-myers-squibb-net-present-value/ 2024-04-16T17:04:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/raludotatug-deruxtecan-daiichi-sankyo-net-present-value/ 2024-07-02T02:11:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/non-viral-vectors-gene-therapy/ 2023-10-03T16:38:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-hit-with-fda-rejection-for-eczema-drug/ 2023-11-29T16:13:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-pays-out-425m-in-court-settlement-over-heartburn-drugs/ 2023-10-03T16:03:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alvotech-partners-with-kashiv-to-develop-and-market-xolair-biosimilar/ 2023-10-09T22:10:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-recommends-oxfords-cheaper-malaria-vaccine/ 2023-10-03T15:28:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-withdraws-cancer-drug-exkivity-after-phase-iii-trial-failure/ 2023-10-03T15:20:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-gsk-endometrial-cancer/ 2023-10-03T10:20:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-janssen-vaccine-e-coli/ 2023-10-03T10:11:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/viatris-divest-businesses/ 2023-10-03T08:10:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-primary-hyperoxaluria-therapy/ 2023-10-03T08:03:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sectors/healthcare/nobel-prize-awarded-for-research-that-paved-the-way-for-covid-19-mrna-vaccines/ 2023-10-13T12:59:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/basilea-pre-emptively-seeks-us-partner-for-ceftobiprole-as-fda-accepts-nda/ 2023-10-02T16:50:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-empaveli-injector-for-pnh-patients/ 2023-10-02T17:35:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-edges-out-competition-to-win-first-fda-approval-for-actemra-biosimilar/ 2023-10-02T15:09:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-lifts-partial-hold-on-phase-iii-plans-for-rare-ataxia-drug/ 2023-10-02T14:44:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-eyes-accelerated-fda-approval-for-iptacopan-across-multiple-indications/ 2023-12-12T14:37:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/medicare-drug-price-negotiations/ 2023-10-02T09:47:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regenerons-bispecific-lymphoma-antibody-odronextamab-wins-fda-priority-review/ 2023-10-02T14:56:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cambridge-biotech-thymmune-wins-37m-nih-grant-for-thymic-cell-therapies/ 2023-09-29T16:10:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/karuna-therapeutics-files-for-fda-approval-for-schizophrenia-treatment/ 2023-09-29T15:42:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/modex-wins-168m-barda-contract-to-develop-viral-antibody-therapies/ 2023-09-29T15:01:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/india-new-gmp-pharma-legislation/ 2023-09-29T14:09:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ai-is-a-pillar-of-the-healthcare-system-of-tomorrow-but-limitations-remain/ 2023-11-06T12:09:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amicus-fda-pompe-disease-therapy/ 2023-09-29T10:05:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hitgen-drug-discovery-partnership/ 2023-09-29T10:02:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deka-advance-product-pipeline/ 2023-09-29T07:59:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fabre-kramer-depressive-disorder-therapy/ 2023-09-29T07:53:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-gains-fda-approval-for-rare-childhood-leukaemia-drug/ 2023-09-28T15:26:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/generative-ai-focused-biotech-startup-evozyne-raises-81m/ 2023-09-28T15:01:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/market-cap-companies-oncology-comparison/ 2023-09-28T14:46:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2023-apprentice-io/ 2024-02-22T09:26:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ono-adimab-oncology-antibody-drugs/ 2023-09-28T09:43:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-rights-ionis-programmes/ 2023-09-28T09:38:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tetra-rare-paediatric-disease-fxs-therapy/ 2023-09-28T08:03:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-entyvio-fda-approval/ 2023-09-28T08:06:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ukraine-russia-academics-brain-drain-cara-war/ 2023-09-27T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glenmark-to-market-winlevi-in-europe-and-south-africa-after-cosmo-deal/ 2023-09-27T16:32:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avalyn-raises-175m-in-funding-to-develop-inhaled-ipf-drugs/ 2023-09-27T15:44:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/galecto-downsizes-by-70-following-phase-ii-trial-failure/ 2023-09-27T15:33:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-and-evotec-launch-translational-drug-discovery-accelerator/ 2023-09-27T15:26:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lillys-176-5m-teva-patent-infringement-loss-overturned-in-us/ 2023-09-28T09:35:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/generics-patients-idiopathic-pulmonary-fibrosis/ 2023-09-27T12:27:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/mobile-health-strategies-should-you-build-or-partner-for-success/ 2023-09-27T16:24:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ukhsa-influenza-vaccine-csl-seqirus/ 2023-09-27T10:01:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arcturus-cystic-fibrosis-deal/ 2023-09-27T09:56:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/milliporesigma-mrna-manufacturing-facilities-germany/ 2023-09-27T12:30:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alfasigma-to-buy-intercept/ 2023-09-27T08:12:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acesion-wins-e45m-in-series-b-funding-to-develop-atrial-fibrillation-therapy/ 2023-09-28T04:30:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/coherus-biosciences-gets-hit-with-crl-for-pegfilgrastim-biosimilar-injectable/ 2023-09-26T18:38:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-scores-european-approval-for-tysabri-biosimilar/ 2023-09-26T18:34:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/signal-big-pharma-embraces-ai-as-novo-nordisk-partners-with-ai-start-up-valo-in-2-7bn-deal/ 2023-09-26T12:32:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-competitive-edge-unlocking-the-full-potential-of-autoinjectors-through-comprehensive-in-house-manufacturing/ 2023-09-26T13:04:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-japanese-approval-rsv-vaccine/ 2023-09-26T09:57:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-valo-therapies/ 2023-09-26T09:51:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-spin-off-sandoz/ 2023-09-26T08:07:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genmab-ec-approval-lymphoma-therapy/ 2023-09-26T08:00:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jordan-fdi-h1-2023-foreign-investment/ 2023-09-25T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/kuwait-fdi-struggle-oil-investment-middle-east/ 2023-09-25T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-alzheimers-disease-medication-approved-in-japan/ 2023-09-25T15:52:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pierre-fabre-announces-another-partnership-to-expand-oncology-rd/ 2023-09-25T15:19:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-ends-multi-million-dollar-cancer-drug-deal-with-i-mab/ 2023-09-25T11:19:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-eyes-first-line-status-for-its-radionucleotide-therapy-lutathera/ 2023-09-25T14:27:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-henlius-oesophageal-cancer/ 2023-09-25T10:15:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valneva-vaccine-contract-us-dod/ 2023-09-25T10:13:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-icr-cancer-drug/ 2023-09-25T08:35:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jardiance-kidney-disease-therapy/ 2023-09-25T08:36:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/germany-business-model-new-economic/ 2023-09-24T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/india-states-foreign-investment-best-performing/ 2023-09-24T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-clears-krystal-biotechs-ind-for-type-1-aatd-treatment-kb408/ 2023-09-22T16:36:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jazz-pharmas-enrylaze-wins-european-approval-for-aml-and-lbl/ 2023-09-28T13:34:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/over-half-world-population-not-covered-by-essential-healthcare-services/ 2023-09-22T13:52:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/alvotechs-avt05-in-phase-iii-rheumatoid-arthritis-study-as-the-sole-candidate/ 2023-09-25T12:34:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jura-bio-syena-tcr-based-therapies/ 2023-09-27T12:30:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cmr-surgical-raises-165m-to-continue-development-of-surgical-robot/ 2023-09-22T10:39:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/yale-and-transcend-wins-us-dod-grant-for-ptsd-therapy/ 2023-09-22T15:36:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-holdings-acquires-paratek/ 2023-09-22T10:37:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glenmark-pharma-divest-stake/ 2023-09-22T08:54:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/debiopharm-sunrock-agreement-cancer-adcs/ 2023-09-22T08:19:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/meitheal-partners-with-chinese-company-for-us-licencing-of-insulin-biosimilars/ 2023-09-21T18:51:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/evaxion-partners-with-afrigen-biologics-to-develop-mrna-gonorrhea-vaccine/ 2023-09-21T17:48:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cymabay-maps-out-regulatory-filing-for-primary-biliary-cholangitis-drug-seladelpar/ 2023-09-21T17:36:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/anaemia-ojjaara-fda-approval/ 2023-09-21T13:46:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kezar-everest-lupus-nephritis/ 2023-09-21T10:37:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-takeda-nda-eosinophilic-esophagitis/ 2023-09-21T10:37:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fresh-tracks-nears-end-of-operations-with-plans-of-dissolution/ 2023-09-21T13:27:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/launching-pharmaceuticals-in-belgium-the-netherlands-and-luxembourg-opportunities-and-challenges/ 2024-01-29T16:59:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-menarini-breast-cancer/ 2023-09-21T08:46:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abcellera-regeneron-expand-antibody-collaboration/ 2023-09-21T08:45:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-foundation-invests-136m-in-new-cell-therapy-facility/ 2023-09-29T01:38:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/germany-fdi-deals-sungeel-hitech-samsung-lg/ 2023-09-20T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-kgaa-links-with-benevolentai-and-exscientia-to-expand-ai-capabilities/ 2023-09-20T17:35:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/addf-invest-in-brainscope-for-alzheimers-prediction-biomarker/ 2023-09-20T15:47:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ars-hits-roadblock-for-neffy-approval-as-fda-requests-additional-study/ 2023-09-20T14:30:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/drug-manufacturing-automation-key-as-populations-age-says-lotte-biologics-ceo/ 2023-09-20T14:04:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-nhs-strikes-show-dangers-of-underfunding-healthcare/ 2023-09-20T14:40:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/peptidream-genentech-drug-deal/ 2023-09-20T10:27:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beigene-novartis-global-rights-tevimbra/ 2023-09-20T10:23:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/taysha-suspends-its-lead-gene-therapy-programme-after-fda-feedback/ 2023-09-27T12:33:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-priority-review-merck/ 2023-09-20T08:30:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-litfulo-severe-alopecia-areata/ 2023-09-20T08:10:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/adgm-seeks-to-boost-sustainable-finance-hub-status-as-cop28-looms/ 2023-09-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kinnate-biopharma-announces-70-layoffs-and-pipeline-restructuring/ 2023-09-19T16:22:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/overcoming-disruptions-in-the-pharmaceutical-supply-chain/ 2023-09-19T13:38:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/otsuka-and-astexs-oral-inaqovi-wins-european-approval-for-aml/ 2023-09-19T13:06:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/60-degrees-pauses-phase-iib-covid-19-trial-for-tafenoquine/ 2023-09-19T10:24:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pelican-merger-primrose-bio/ 2023-09-19T10:09:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orexo-fda-opioid-overdose-therapy/ 2023-09-19T10:04:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-cepi-mpox-vaccine/ 2023-09-20T08:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmanovia-acquisition-sanofi-cns-brands/ 2023-09-19T08:29:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/puxitatug-samrotecan-astrazeneca-net-present-value/ 2024-07-02T02:11:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tocilizumab-biosimilar-celltrion-net-present-value/ 2024-12-13T02:53:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/risvodetinib-inhibikase-therapeutics-net-present-value/ 2024-05-16T01:56:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pds-0101-pds-biotechnology-net-present-value/ 2024-06-13T18:54:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dexamethasone-acetate-oculis-net-present-value/ 2024-06-13T18:49:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dexmethylphenidate-hydrochloride-cingulate-net-present-value/ 2024-06-13T18:54:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/licaminlimab-oculis-net-present-value/ 2024-04-16T17:03:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ezobresib-bristol-myers-squibb-net-present-value/ 2024-06-13T18:54:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/admilparant-bristol-myers-squibb-net-present-value/ 2024-06-13T18:54:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/best-performing-us-states-foreign-investment-2022/ 2023-09-18T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bulgaria-fdi-2023-january-june-euopre/ 2024-03-27T23:48:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vietnam-rikkeisoft-investment-us/ 2024-03-27T23:48:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/outsourcing-trends-in-clinical-trials-how-one-company-is-reimagining-the-fsp-model/ 2023-11-28T15:15:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-revises-biosimilar-guidelines-for-clearer-drug-labelling/ 2023-09-18T14:25:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emas-chmp-supports-almiralls-ebglyss-for-atopic-dermatitis/ 2023-09-19T00:06:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novo-nordisk-wegovy-nhs-supply/ 2023-09-18T14:07:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/are-otc-oral-contraceptives-america-answer-to-roe-versus-wade/ 2023-09-18T14:03:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-gsks-ojjaara-for-treating-myelofibrosis-patients-with-anaemia/ 2023-09-18T13:27:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-pharma-wants-to-break-the-efficacy-ceiling-in-ibd/ 2023-09-18T13:02:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/illumina-leads-15m-investment-in-broken-string-biosciences/ 2023-09-20T04:59:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-receives-ema-chmp-approval-for-herceptin-biosimilar/ 2023-09-18T12:10:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/host-cell-protein-analytics-history-and-future-trends/ 2023-09-18T15:46:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/how-to-connect-patients-with-rare-diseases-to-clinical-trials/ 2023-09-18T09:20:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rare-disease-drug-development-needs-regulatory-incentives-to-grow-in-2024/ 2023-09-18T08:58:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sparingvision-shares-trial-updates-for-rare-eye-disease-gene-therapies/ 2023-09-20T08:46:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-idorsias-chronic-insomnia-treatment-for-uk-patients/ 2023-09-15T15:56:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/remote-patient-monitoring-market-will-reach-760m-by-2030/ 2023-09-15T15:48:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iovance-pdufa-date-for-lifileucel-pushed-due-to-fda-backlog/ 2023-09-15T15:44:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/argenx-wins-ema-chmp-nod-for-subcutaneous-vyvgart-in-myasthenia-gravis/ 2023-09-15T14:20:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cure-genetics-frametact-gene-therapy/ 2023-09-15T10:29:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/market-cap-rebound-by-top-20-biopharmaceutical-companies-in-q2-2023/ 2023-09-15T09:51:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/generatebiomedicines-advance-therapeutic-portfolio/ 2023-09-15T10:00:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/no-more-cookies-how-healthcare-companies-can-gain-trust-for-data-consent/ 2023-12-14T12:20:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-approval-moderna-vaccine/ 2023-09-15T08:47:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/charles-river-related-sciences-ai-drug/ 2023-09-15T08:48:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/uzbekistan-ifc-fdi-central-asia-legal-framework/ 2024-03-27T23:48:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cd123-targeted-car-nk-chongqing-precision-biotech-refractory-acute-myeloid-leukemia-likelihood-of-approval/ 2024-09-09T01:34:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cd123-targeted-car-nk-chongqing-precision-biotech-relapsed-acute-myeloid-leukemia-likelihood-of-approval/ 2024-09-09T01:34:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jte-162-japan-tobacco-inflammation-likelihood-of-approval/ 2023-09-14T16:24:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jte-162-japan-tobacco-autoimmune-disorders-likelihood-of-approval/ 2023-09-14T16:24:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/npx-267-nextpoint-therapeutics-pancreatic-ductal-adenocarcinoma-likelihood-of-approval/ 2025-01-20T16:15:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mar-001-marea-therapeutics-hypertriglyceridemia-likelihood-of-approval/ 2023-09-14T16:22:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cerewint-regeneration-biomedical-alzheimer-s-disease-likelihood-of-approval/ 2023-09-14T16:21:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vent-02-ventus-therapeutics-neuroinflammation-likelihood-of-approval/ 2024-05-20T02:56:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sj-01-shanghai-bao-pharmaceuticals-anemia-likelihood-of-approval/ 2025-01-20T16:15:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vent-02-ventus-therapeutics-neurodegenerative-diseases-likelihood-of-approval/ 2024-05-20T02:56:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mt-302-myeloid-therapeutics-metastatic-colorectal-cancer-likelihood-of-approval/ 2025-01-20T16:15:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cst-2032-nadolol-curasen-therapeutics-dementia-likelihood-of-approval/ 2024-06-14T04:08:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sk-10-guangzhou-zhiyi-biotechnology-chemotherapy-induced-diarrhea-cid-likelihood-of-approval/ 2023-09-14T16:20:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mesenchymal-stem-cells-derived-exosomes-celltex-therapeutics-alzheimer-s-disease-likelihood-of-approval/ 2023-09-14T16:19:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pbcar-19b-precision-biosciences-mantle-cell-lymphoma-likelihood-of-approval/ 2024-05-20T02:55:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sysa-1801-elevation-oncology-metastatic-pancreatic-cancer-likelihood-of-approval/ 2025-01-19T16:37:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nb-4746-nura-bio-amyotrophic-lateral-sclerosis-likelihood-of-approval/ 2023-09-14T16:19:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bgb-10188-beigene-peritoneal-cancer-likelihood-of-approval/ 2025-01-20T16:15:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bgb-10188-beigene-epithelial-ovarian-cancer-likelihood-of-approval/ 2025-01-20T16:15:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bgb-10188-beigene-fallopian-tube-cancer-likelihood-of-approval/ 2025-01-20T16:15:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leo-152020-leo-pharma-atopic-dermatitis-atopic-eczema-likelihood-of-approval/ 2024-07-05T06:17:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/osemitamab-transcenta-metastatic-biliary-tract-cancer-likelihood-of-approval/ 2025-01-20T16:15:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/navenibart-astria-therapeutics-hereditary-angioedema-hae-c1-esterase-inhibitor-c1-inh-deficiency-likelihood-of-approval/ 2025-01-20T16:15:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tnx-1500-tonix-pharmaceuticals-holding-heart-transplant-rejection-likelihood-of-approval/ 2024-09-09T04:17:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tnx-1500-tonix-pharmaceuticals-holding-systemic-lupus-erythematosus-likelihood-of-approval/ 2024-09-09T04:17:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tnx-1500-tonix-pharmaceuticals-holding-kidney-transplant-rejection-likelihood-of-approval/ 2024-09-09T04:17:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tnx-1500-tonix-pharmaceuticals-holding-sicca-syndrome-sjogren-likelihood-of-approval/ 2024-09-09T04:17:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tnx-1500-tonix-pharmaceuticals-holding-rheumatoid-arthritis-likelihood-of-approval/ 2024-09-09T04:17:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ociperlimab-beigene-small-cell-lung-cancer-likelihood-of-approval/ 2024-09-09T04:17:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/csx-1004-cessation-therapeutics-opium-opioid-addiction-likelihood-of-approval/ 2024-03-18T23:36:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yh-25724-boehringer-ingelheim-international-obesity-likelihood-of-approval/ 2025-01-20T02:16:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lunresertib-repare-therapeutics-metastatic-colorectal-cancer-likelihood-of-approval/ 2025-01-19T16:36:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lunresertib-repare-therapeutics-ovarian-cancer-likelihood-of-approval/ 2025-01-19T16:36:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/m-701-wuhan-yzy-biopharma-malignant-ascites-likelihood-of-approval/ 2025-01-20T02:16:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vg-161-virogin-biotech-metastatic-hepatocellular-carcinoma-hcc-likelihood-of-approval/ 2025-01-20T02:16:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/actus-101-asklepios-biopharmaceutical-pompe-disease-likelihood-of-approval/ 2023-09-14T16:11:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/golexanolone-umecrine-cognition-hepatic-encephalopathy-likelihood-of-approval/ 2023-09-14T16:10:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/marstacimab-pfizer-hemophilia-a-factor-viii-deficiency-likelihood-of-approval/ 2025-01-20T02:15:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gamma-pn-gpn-vaccines-streptococcal-pneumonia-likelihood-of-approval/ 2023-09-14T16:10:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/livmoniplimab-abbvie-metastatic-hepatocellular-carcinoma-hcc-likelihood-of-approval/ 2024-09-09T04:06:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pen-866-tarveda-therapeutics-ovarian-cancer-likelihood-of-approval/ 2025-01-20T02:15:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pen-866-tarveda-therapeutics-colorectal-cancer-likelihood-of-approval/ 2025-01-20T02:15:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pen-866-tarveda-therapeutics-gastric-cancer-likelihood-of-approval/ 2025-01-20T02:15:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pen-866-tarveda-therapeutics-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-20T02:15:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pen-866-tarveda-therapeutics-pancreatic-ductal-adenocarcinoma-likelihood-of-approval/ 2025-01-20T02:15:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apraglutide-ironwood-pharmaceuticals-short-bowel-syndrome-likelihood-of-approval/ 2023-09-14T16:09:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cemiplimab-regeneron-pharmaceuticals-merkel-cell-carcinoma-likelihood-of-approval/ 2025-01-20T02:15:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/livmoniplimab-abbvie-metastatic-hepatocellular-carcinoma-hcc-likelihood-of-approval-2/ 2025-01-20T02:15:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/islasertib-thryv-therapeutics-arrhythmias-likelihood-of-approval/ 2023-09-14T16:07:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olx-07010-oligomerix-progressive-supranuclear-palsy-likelihood-of-approval/ 2025-01-20T02:15:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azeliragon-cantex-pharmaceuticals-refractory-brain-metastasis-likelihood-of-approval/ 2025-01-20T02:14:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gsk-1070806-gsk-atopic-dermatitis-atopic-eczema-likelihood-of-approval/ 2025-01-20T02:14:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ixabepilone-r-pharm-us-fallopian-tube-cancer-likelihood-of-approval/ 2025-01-20T02:14:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ixabepilone-r-pharm-us-peritoneal-cancer-likelihood-of-approval/ 2025-01-20T02:14:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ixabepilone-r-pharm-us-epithelial-ovarian-cancer-likelihood-of-approval/ 2025-01-20T02:14:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/obexelimab-zenas-biopharma-usa-acquired-autoimmune-hemolytic-anemia-likelihood-of-approval/ 2025-01-20T02:14:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-use-of-vydura-for-acute-migraines-on-the-nhs/ 2023-09-14T15:31:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alnylams-rna-interference-drug-wins-favour-of-fda-adcom/ 2023-09-14T15:18:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/first-wave-plans-to-repurpose-sanofis-capeserod-as-gi-therapy/ 2023-09-14T14:50:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/icon-partners-with-us-government-for-clinical-trials-of-covid-19-vaccines/ 2023-10-02T15:47:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmazz-sun-pharma-tyvalzi/ 2023-09-14T10:13:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-drug-production-ireland/ 2023-09-14T10:03:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/improving-health-equity-in-europes-small-countries-how-can-we-remove-the-barriers-to-access/ 2024-01-29T16:57:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abcellera-incyte-cancer-antibodies/ 2023-09-14T08:59:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/madrigal-pharmaceuticals-nda-liver-disease/ 2023-09-14T09:03:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/romania-fdi-slump-first-half-of-2023/ 2024-03-27T23:48:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/expected-tax-exemptions-in-egypt-will-entice-strategic-industries/ 2024-03-27T23:48:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/samsung-poses-threat-to-taiwan-semiconductor/ 2023-09-13T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/corporate-sustainability-needs-esg-standards-and-tools/ 2023-09-15T08:00:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avalo-drops-three-rare-disease-assets-amid-ongoing-challenges/ 2023-09-13T16:28:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/results-from-rybrevant-trial-solidify-janssen-foothold-in-egfr-mutated-nsclc/ 2023-09-13T15:36:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bristol-myers-squibb-reblozyl-reinforces-market-share-in-first-line-mds-space/ 2023-09-13T15:29:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-to-start-review-of-subcutaneous-entyvio-for-crohns-disease/ 2023-09-13T14:52:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-calls-out-eight-companies-for-selling-unapproved-eye-drugs/ 2023-09-13T14:16:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vaxess-raises-9m-to-accelerate-mrna-vaccine-patch-development/ 2023-09-13T17:49:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/do-diet-drugs-pull-their-weight/ 2023-09-13T12:50:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-to-refile-subcutaneous-tecentriq-with-fda-after-uk-approval/ 2023-09-14T09:44:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/menarini-astellas-rheumatoid-arthritis/ 2023-09-13T10:25:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dewpoint-chemify-drug-discovery/ 2023-09-13T10:24:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/axolotl-carmell-merger-deal/ 2023-09-13T08:46:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eli-lilly-mounjaro-approved-on-nhs-for-use-in-type-2-diabetes/ 2023-09-13T07:52:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hasten-lib-cvd-drug/ 2023-09-13T08:44:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/corporate-sustainability-needs-esg-standards-and-tools-2/ 2023-09-12T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/israel-records-slump-fdi-first-quarter-2023/ 2023-09-12T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/2seventy-bio-fires-40-of-staff-after-reduced-abecma-sales-forecasts/ 2023-09-13T09:49:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancervax-joins-forces-with-ucla-to-develop-a-universal-car-t-cell-therapy/ 2023-09-13T09:49:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-and-bms-invest-in-dark-genome-focused-company-rome-therapeutics/ 2023-09-13T09:49:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biolinerx-aphexda-fda-approval/ 2023-09-12T10:46:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gardp-orchid-antibiotic-deal/ 2023-09-12T10:48:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-pfizer-omicron-adapted-vaccine/ 2023-09-12T08:44:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-recalls-sandimmune-solution/ 2023-09-12T08:39:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/signal-hhs-regeneron-covid-19-deal-includes-list-price-clause-for-affordability/ 2023-09-12T09:03:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-partners-with-samsung-bioepis-to-license-stelara-biosimilar/ 2023-09-11T15:02:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2023-viedoc/ 2024-02-22T09:26:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/verona-pharmas-ensifentrine-inches-closer-to-approval-decision-in-copd/ 2023-09-11T14:05:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/why-prefilled-vial-capacity-is-key-to-a-competitive-edge-in-pharmaceuticals-manufacturing/ 2026-04-07T10:14:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kroger-to-pay-up-to-1-4bn-to-settle-opioid-crisis-lawsuits/ 2023-09-12T04:49:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/coherus-acquires-surface/ 2023-09-11T10:32:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/grit-funds-pipeline-development/ 2023-09-13T09:49:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biosyngen-receives-fda-approval-to-start-phase-i-trial-for-tcr-therapy/ 2023-09-11T14:03:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-ema-urothelial-cancer/ 2023-09-11T08:37:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alexion-verge-drug-deal/ 2023-09-11T08:34:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/lord-james-hopes-uk-commercial-clinical-trials/ 2023-09-14T08:23:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/what-does-csrd-mean-for-the-pharmaceutical-industry-engie-impact-explains/ 2023-09-21T11:49:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/calibrating-cold-chain-systems-for-cell-and-gene-therapies-in-a-post-pandemic-world/ 2023-09-13T09:49:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/three-seas-initiative-investment-options-ukraine/ 2023-09-10T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/digital-dilemma-in-uks-life-sciences-job-market/ 2023-09-20T20:44:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/hope-uk-clinical-trial-landscape/ 2023-09-08T16:23:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-track-mendus-acute-myeloid-leukaemia-vaccine-vividencel/ 2023-09-13T09:49:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eloxx-moves-ahead-with-plans-with-gene-therapy-for-rare-kidney-disorder/ 2023-09-08T15:28:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/record-number-respiratory-syncytial-virus-rsv-designations-2022/ 2023-09-08T12:33:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/otsuka-shapetx-gene-therapies/ 2023-09-13T09:46:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-lilly-tirzepatide-diabetes/ 2023-09-08T09:32:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-merck-ebola-vaccine/ 2023-09-08T08:57:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocytogen-myricx-bio-adcs/ 2023-09-08T07:33:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/subcutaneous-drugs-grant-a-new-lease-on-life-to-checkpoint-inhibitors/ 2023-09-08T16:05:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-rejoins-eus-horizon-europe-science-programme/ 2023-09-08T09:35:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssens-patient-programme-becomes-latest-victim-of-data-breach/ 2023-09-07T14:41:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cidara-gets-a-nod-from-janssen-to-continue-cd388-flu-prevention-programme/ 2023-09-07T13:49:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/veracyte-gustave-roussy-partnership-cancer-therapies/ 2023-09-07T10:40:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/imidomics-licence-tnax-drug/ 2023-09-07T10:40:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-drug-diabetes/ 2023-09-07T08:50:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apollo-advance-pipeline-programmes/ 2023-09-07T08:53:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/signal-nimbus-raises-210m-to-foster-drug-discovery-plans/ 2023-09-07T10:40:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/g20-global-poverty-financial-inclusion-fdi/ 2023-09-06T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-reserach-uk-trials-overseas/ 2023-09-08T16:10:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-mulls-risk-strategy-for-ultomiris-following-fda-response-letter/ 2023-09-06T15:56:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/idorsia-reacquires-aprocitentan-rights-from-janssen-for-343m/ 2023-09-06T14:57:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mirum-expands-rare-disease-portfolio-with-digestive-disorder-drugs/ 2023-09-06T14:56:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-carbon-negative-2030/ 2023-09-06T13:30:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tc-biopharm-mucosal-infection/ 2023-09-06T09:51:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-pfizer-adapted-vaccine/ 2023-09-06T09:55:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-latest-pharma-giant-to-spin-off-generics-brand-sandoz/ 2023-09-06T13:16:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zenas-bms-antibody-deal/ 2023-09-06T08:40:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-viatris-hiv-children/ 2023-09-06T08:38:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uae-gambling-gaming-regulator-casinos-dubai/ 2023-09-05T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nestle-divests-peanut-allergy-treatment-palforzia-to-stallergenes-greer/ 2023-09-05T16:46:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/doac-positive-effects-on-cancer-associated-vte/ 2023-09-05T14:42:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/star-therapeutics-raises-90m-in-funding-to-advance-antibody-therapies/ 2023-09-05T14:33:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/launching-pharmaceuticals-in-the-nordics-opportunities-and-challenges/ 2024-01-29T16:55:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/new-2023-guidelines-for-the-management-of-cardiomyopathies/ 2023-09-05T14:24:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/vte-risk-swedish-patients-hospitalised-covid-19/ 2023-09-05T13:31:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/invios-cell-therapy-secures-austrian-government-grant-for-phase-ib-trial/ 2023-09-06T15:21:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/focus-clinical-research-uk-all-nhs/ 2023-09-06T08:01:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cipla-acquisition-actor-pharma/ 2023-09-05T10:30:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-abbvie-migraine-aquipta/ 2023-09-05T10:27:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-nmpa-astrazeneca-calquence/ 2023-09-05T08:38:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tetris-pharma-goodlife-agreement-ogluo/ 2023-09-05T08:13:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/signal-novo-nordisks-wegovy-enters-new-borders/ 2023-09-05T10:31:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/centogene-finds-diagnostic-and-predictive-biomarker-for-gaucher-disease/ 2023-09-04T14:31:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-horizon-therapeutics-settle-ftc-lawsuit/ 2023-09-04T11:06:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-clinical-trials-provider-ergomed-bought-by-permira/ 2023-09-06T07:45:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bidco-biopharmaceutical-services-company-ergomed/ 2023-09-04T10:52:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/intron-wins-us-army-contract-to-develop-bacteriophages-for-e-coli-infections/ 2023-09-04T10:23:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-gsk-nucala-application-rhinosinusitis/ 2023-09-04T08:37:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocon-generics-purchases-eywas-facility/ 2023-09-04T08:39:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/minimal-impact-first-ten-drugs-medicare-price-negotiation/ 2023-09-04T10:36:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/portugal-inward-fdi-first-half-h1-2023/ 2023-09-03T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/sustainability-in-the-biopharma-industry-the-way-forward/ 2024-03-14T08:58:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sage-therapeutics-fires-40-of-staff-after-fda-rejected-mdd-bid/ 2023-09-01T15:44:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/neximmune-to-lay-off-over-half-of-its-employees/ 2023-09-06T15:19:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-benefits-of-using-an-app-to-manage-gestational-diabetes-nikis-story/ 2023-11-23T11:45:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-looks-to-expand-kerendia-label-to-include-heart-failure/ 2023-09-01T14:53:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-market-cap-higher-than-danish-gdp-obesity-drugs/ 2023-09-01T11:35:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/changing-guard-expected-the-crohns-disease-marketplace/ 2023-09-01T10:03:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/reset-filament-licence-psilocybin/ 2023-09-01T10:34:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/huadong-deal-mc2-therapeutics/ 2023-09-01T09:30:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/otsuka-pharmaceutical-mindset-pharma/ 2023-09-01T08:06:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/twist-ono-antibodies-autoimmune-diseases/ 2023-09-01T08:04:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zerva-acquires-acer-therapeutics-to-bolster-rare-disease-portfolio/ 2024-11-06T09:28:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-issues-guidance-on-using-real-world-data-for-drug-development/ 2024-11-14T13:32:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/enhertu-wins-two-fda-breakthrough-therapy-designations/ 2023-08-31T15:23:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alkermes-fends-off-generic-versions-of-vivitrol-until-2027/ 2023-08-31T15:34:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nmpa-zai-labs-repotrectinib/ 2023-08-31T10:34:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/serina-merge-subsidiary-agex/ 2023-08-31T10:16:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/signal-apellis-sheds-staff-weight-plus-rd-in-a-bid-to-restructure-company/ 2023-08-31T11:48:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-biontechs-covid-19-vaccine/ 2023-08-31T08:05:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-embark-metabolic-programme/ 2023-08-31T08:42:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cell-gene-therapy-in-pharma/ 2024-08-20T09:15:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/is-fdi-in-trouble-foreign-investment/ 2023-08-30T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-shuns-outlook-therapeutics-with-wet-amd-drug-bla-rejection/ 2023-08-30T15:58:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/codagenix-pursues-rsv-vaccine-development-amid-unexpected-challenges/ 2023-08-30T15:26:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-wins-first-approval-for-subcutaneous-tecentriq/ 2023-09-25T19:55:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-zealand-pharma-dasiglucagon/ 2023-08-30T11:08:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fibrogens-pamrevlumab-disappointing-results-marks-second-failure-in-a-row/ 2023-08-30T13:56:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biostax-immgenuity-hiv-immunotherapies/ 2023-08-30T10:09:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-approval-merck-keytruda/ 2023-08-30T08:03:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alvotech-bioventure-biosimilar-egypt/ 2023-08-30T08:32:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/artificial-intelligence-in-pharma/ 2024-08-20T09:29:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/big-data-in-pharma/ 2024-08-20T09:21:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/internet-of-things-in-pharma/ 2024-06-03T07:46:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/precision-and-personalized-medicine-in-pharma/ 2024-05-31T10:52:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/immuno-oncology-in-pharma/ 2024-05-31T10:53:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/virtual-care-in-pharma/ 2024-06-03T07:39:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roches-evrysdi-secures-ec-approval-for-spinal-muscular-atrophy-in-infants/ 2023-08-30T10:31:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-accepts-valnevas-chikungunya-vaccine-filing-for-review/ 2023-08-29T15:27:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-announces-first-ten-drugs-up-for-medicare-price-negotiation/ 2023-08-29T16:50:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/zelasudil-idiopathic-pulmonary-fibrosis-potential/ 2023-08-29T12:55:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-risankizumab-fda-and-ema/ 2023-08-29T10:47:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-leqvio-shows-up-to-50-cholesterol-reduction-over-six-years/ 2023-08-29T15:39:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bristol-myers-squibb-fda-reblozyl/ 2023-08-29T10:26:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/clinical-trials-how-ai-can-help-providers-stay-tmf-inspection-ready/ 2023-08-29T13:56:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/european-pfas-ban-burden-packagers/ 2023-08-29T09:48:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/danaher-acquires-abcam/ 2023-08-29T10:40:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-collaborates-immunogen-elahere/ 2023-08-29T20:05:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/qa-how-the-henrietta-lacks-settlement-challenges-our-view-of-bioethics/ 2023-08-28T16:28:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/signal-pharma-gears-up-for-ira-driven-drug-price-negotiation-list-by-cms/ 2023-08-29T09:35:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/specialised-therapeutics-treeway-als/ 2023-08-28T13:31:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/phebra-university-of-wollongong-cancer-therapies/ 2023-08-28T11:22:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-acquisition-mycamine-antifungal-astellas/ 2023-08-28T09:58:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-sbla-fda-nsclc-therapy/ 2023-08-28T08:35:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gc-biopharma-cholera-vaccine/ 2023-08-28T07:00:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allina-health-no-longer-bar-indebted-patients-from-care/ 2023-08-30T08:06:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/patidistrogene-bexoparvovec-sarepta-therapeutics-net-present-value/ 2024-06-13T18:48:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nx-5948-nurix-therapeutics-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2025-01-20T02:12:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trastuzumab-rezetecan-jiangsu-hengrui-medicine-adenocarcinoma-of-the-gastroesophageal-junction-likelihood-of-approval/ 2025-01-20T02:12:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trastuzumab-rezetecan-jiangsu-hengrui-medicine-human-epidermal-growth-factor-receptor-2-positive-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2025-01-20T02:12:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thiscart19a-suzhou-fundamenta-therapeutics-b-cell-non-hodgkin-lymphoma-likelihood-of-approval/ 2025-01-20T02:12:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thiscart19a-suzhou-fundamenta-therapeutics-b-cell-acute-lymphocytic-leukemia-b-cell-acute-lymphoblastic-leukaemia-likelihood-of-approval/ 2025-01-20T02:12:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trastuzumab-rezetecan-jiangsu-hengrui-medicine-gastric-cancer-likelihood-of-approval/ 2025-01-20T02:12:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/uwc-19-uwell-biopharma-lymphoblastic-lymphoma-likelihood-of-approval/ 2024-09-09T03:28:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/uwc-19-uwell-biopharma-b-cell-non-hodgkin-lymphoma-likelihood-of-approval/ 2024-09-09T03:28:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/uwc-19-uwell-biopharma-mantle-cell-lymphoma-likelihood-of-approval/ 2024-09-09T03:28:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/uwc-19-uwell-biopharma-burkitt-lymphoma-likelihood-of-approval/ 2024-09-09T03:28:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/uwc-19-uwell-biopharma-follicular-lymphoma-likelihood-of-approval/ 2024-09-09T03:28:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/raludotatug-deruxtecan-daiichi-sankyo-ovarian-cancer-likelihood-of-approval/ 2025-01-20T02:11:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lbs-007-lin-bioscience-myelodysplastic-syndrome-likelihood-of-approval/ 2023-08-28T03:35:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ezabenlimab-boehringer-ingelheim-international-gastric-cancer-likelihood-of-approval/ 2025-01-20T02:11:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lisaftoclax-ascentage-pharma-group-international-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2025-01-20T02:11:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lbs-007-lin-bioscience-chronic-myelocytic-leukemia-cml-chronic-myeloid-leukemia-likelihood-of-approval/ 2023-08-28T03:34:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xgeva-amgen-letterer-siwe-disease-multifocal-and-multisystemic-disseminated-langerhans-cell-histiocytosis-likelihood-of-approval/ 2024-09-09T03:27:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ifezuntirgene-inilparvovec-uniqure-huntington-disease-likelihood-of-approval/ 2024-05-20T02:50:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bintrafusp-alfa-merck-bladder-cancer-likelihood-of-approval/ 2025-01-20T02:11:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/poseltinib-hanmi-pharmaceuticals-autoimmune-disorders-likelihood-of-approval/ 2025-01-20T02:11:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aldesleukin-iltoo-pharma-bipolar-disorder-manic-depression-likelihood-of-approval/ 2025-01-20T02:11:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bempedoic-acid-esperion-therapeutics-hypercholesterolemia-likelihood-of-approval/ 2025-01-20T02:10:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rifaximin-alfasigma-collagenous-colitis-likelihood-of-approval/ 2025-01-20T02:10:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/belinostat-acrotech-biopharma-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2025-01-20T02:10:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mil-62-beijing-mabworks-biotech-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2025-01-20T02:10:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/per-001-perfuse-therapeutics-diabetic-retinopathy-likelihood-of-approval/ 2024-06-20T15:20:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrna-1018-moderna-pandemic-influenza-likelihood-of-approval/ 2023-08-28T03:28:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denosumab-amgen-metastatic-melanoma-likelihood-of-approval/ 2025-01-20T02:10:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/obinutuzumab-f-hoffmann-la-roche-hairy-cell-leukemia-likelihood-of-approval/ 2024-09-09T02:28:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/emdmx-1-emyria-post-traumatic-stress-disorder-ptsd-likelihood-of-approval/ 2023-08-28T03:27:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sys-6010-cspc-pharmaceutical-group-breast-cancer-likelihood-of-approval/ 2025-01-20T02:13:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sys-6010-cspc-pharmaceutical-group-colorectal-cancer-likelihood-of-approval/ 2025-01-20T02:13:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sys-6010-cspc-pharmaceutical-group-head-and-neck-cancer-likelihood-of-approval/ 2025-01-20T02:13:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sys-6010-cspc-pharmaceutical-group-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-20T02:14:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sys-6010-cspc-pharmaceutical-group-squamous-non-small-cell-lung-carcinoma-likelihood-of-approval/ 2025-01-20T02:14:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mt-302-myeloid-therapeutics-cervical-cancer-likelihood-of-approval/ 2025-01-20T02:13:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mt-302-myeloid-therapeutics-gastric-cancer-likelihood-of-approval/ 2025-01-20T02:13:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mt-302-myeloid-therapeutics-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-20T02:13:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mt-302-myeloid-therapeutics-esophageal-cancer-likelihood-of-approval/ 2025-01-20T02:13:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mt-302-myeloid-therapeutics-pancreatic-ductal-adenocarcinoma-likelihood-of-approval/ 2025-01-20T02:13:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mt-302-myeloid-therapeutics-metastatic-transitional-urothelial-tract-cancer-likelihood-of-approval/ 2025-01-20T02:13:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mt-302-myeloid-therapeutics-epithelial-ovarian-cancer-likelihood-of-approval/ 2025-01-20T02:13:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mt-302-myeloid-therapeutics-human-epidermal-growth-factor-receptor-2-negative-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2025-01-20T02:13:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mt-302-myeloid-therapeutics-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2025-01-20T02:13:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pl-001-pell-bio-med-technology-follicular-lymphoma-likelihood-of-approval/ 2024-06-14T04:05:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lr-20062-lg-chem-pertussis-whooping-cough-likelihood-of-approval/ 2025-01-20T02:13:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mdi-1228-henan-maiyingnuo-pharmaceutical-technology-allergic-conjunctivitis-likelihood-of-approval/ 2023-08-28T03:27:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aroc-3-arrowhead-pharmaceuticals-iga-nephropathy-berger-s-disease-likelihood-of-approval/ 2023-08-28T03:25:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/huc-2344-huons-type-2-diabetes-likelihood-of-approval/ 2023-08-28T03:24:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wu-nk-101-wugen-refractory-acute-myeloid-leukemia-likelihood-of-approval/ 2023-08-28T03:24:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wu-nk-101-wugen-relapsed-acute-myeloid-leukemia-likelihood-of-approval/ 2023-08-28T03:24:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nx-5948-nurix-therapeutics-mantle-cell-lymphoma-likelihood-of-approval/ 2025-01-20T02:12:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nx-5948-nurix-therapeutics-follicular-lymphoma-likelihood-of-approval/ 2025-01-20T02:12:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nx-5948-nurix-therapeutics-waldenstrom-macroglobulinemia-lymphoplasmacytic-lymphoma-likelihood-of-approval/ 2025-01-20T02:12:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nx-5948-nurix-therapeutics-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2025-01-20T02:12:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jnj-2113-johnson-johnson-plaque-psoriasis-psoriasis-vulgaris-likelihood-of-approval/ 2025-01-20T02:12:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/insulin-efsitora-alfa-eli-lilly-and-co-net-present-value/ 2024-06-13T18:54:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tremtelectogene-empogeditemcel-vor-biopharma-net-present-value/ 2024-07-02T02:02:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sonrotoclax-beigene-net-present-value/ 2024-05-16T02:08:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kpi-012-kala-bio-net-present-value/ 2024-07-02T02:09:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/transcon-il-2-beta-gamma-ascendis-pharma-net-present-value/ 2024-07-02T02:10:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-the-first-tysabri-biosimilar-for-ms-and-crohns-disease/ 2023-08-25T17:10:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/microbiome-company-enterome-plans-108m-raise-to-fund-phase-ii-cancer-trials/ 2023-08-25T17:07:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-scores-its-second-paediatric-approval-for-soliris-in-japan/ 2023-08-25T17:00:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wegovy-can-reduce-heart-failure-symptoms-in-obese-patients-study-shows/ 2023-08-25T16:51:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pfizer-antibody-elrexfio-rrmm/ 2023-08-25T15:15:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-thermo-fisher-wegovy/ 2023-08-25T10:57:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-gilead-snda-veklury/ 2023-08-25T10:42:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-whistle-blower-policy-questioned-lucy-letby/ 2023-08-30T13:22:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/five-ways-to-build-trust-in-patient-data-sharing/ 2023-12-14T11:52:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-astrazeneca-lynparza-japan/ 2023-08-25T08:37:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-approves-pfizers-rsv-vaccine-for-older-adults-and-pregnant-women/ 2023-08-25T08:49:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cvs-health-enters-biosimilar-fray-with-launch-of-new-subsidiary/ 2024-01-04T10:56:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-elections-vivek-ramaswamy-makes-brazen-debate-debut/ 2023-08-24T16:37:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novaliq-pursues-ema-approval-for-dry-eye-disease-drug/ 2023-08-24T16:11:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sk-bioscience-and-vaxxas-partner-to-develop-needle-free-typhoid-vaccine-patch/ 2023-08-24T15:48:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/diabetic-macular-oedema-market-9-6bn-7mm-2031/ 2023-08-24T13:24:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/uk-life-sciences-grapple-with-the-job-markets-digital-dilemma/ 2023-08-28T14:14:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/xnk-partners-with-swedish-hospital-to-develop-aml-therapy/ 2023-08-24T15:34:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fore-plixorafenib-development/ 2023-08-24T10:02:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-patent-bioarctic-antibody/ 2023-08-24T09:49:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dizal-approval-china-nsclc-therapy/ 2023-08-24T08:10:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cellares-cell-therapy-facility/ 2023-08-30T08:54:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/signal-gileads-targets-inflammation-and-cancer-with-tentatrix-partnership/ 2023-08-30T12:53:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brics-invites-six-nations-including-saudi-arabia-and-iran-to-join-alliance/ 2023-08-23T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/saudi-arabia-joins-un-convention-on-contracts-for-the-international-sale-of-goods/ 2023-08-23T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celcuity-teams-up-with-bayer-for-phase-ib-ii-prostate-cancer-trial/ 2023-08-23T15:51:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sales-reps-ai-messaging/ 2023-08-23T15:43:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apellis-discontinues-some-syfovre-injection-kits-due-to-safety-risks/ 2023-08-23T14:43:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-signs-commercialisation-deal-for-mahanas-digital-therapeutics-range/ 2023-08-24T10:29:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-partners-with-us-government-to-develop-covid-19-antibody-vaccine/ 2023-08-23T14:28:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-bristol-myers-opdivo-melanoma/ 2023-08-23T10:30:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/does-ai-ml-make-cros-obsolete-it-depends/ 2023-08-23T10:33:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-daiichi-sankyo-enhertu/ 2023-08-23T10:01:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/obesity-t2d-drugs-novo-nordisk-eli-lilly/ 2023-08-23T09:13:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chinese-economic-slump-hurts-pharma/ 2023-08-30T07:58:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hhs-grant-covid-vaccines/ 2023-08-23T07:53:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/revive-next-generation-bucillamine/ 2023-08-23T08:18:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/halia-plans-two-trials-testing-its-anti-inflammatory-lead-candidate/ 2023-08-22T17:39:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-talvey-adds-european-approval-on-top-of-its-us-authorisation/ 2023-08-22T15:05:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-a-flexible-fsp-model-fills-the-talent-gap/ 2023-11-28T15:15:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ocugen-plans-two-phase-i-ii-trials-in-macular-disease/ 2023-08-22T14:47:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uthsc-treatments-for-ptoa/ 2023-08-22T10:00:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/qualifyze-pharma-supply-chain-compliance/ 2023-08-22T08:18:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-pfizer-rsv-vaccine/ 2023-08-22T08:57:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-industry-4-0-is-changing-pharmaceutical-supply-chains/ 2023-08-24T15:23:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/leo-pharma-timber-pharmaceuticals/ 2023-08-22T08:54:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/migrant-led-start-ups-do-better-founder-of-on-way-ventures/ 2023-08-21T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genesis-therapeutics-200m-series-b/ 2023-08-21T15:53:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-veopoz-fda-approval-rare-immune-disease/ 2023-08-22T09:03:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/calliditas-closer-full-approval-iga-nephropathy-drug/ 2023-08-21T14:19:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-effective-communications-can-improve-patient-engagement-in-clinical-trials/ 2023-08-31T09:30:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/functional-foods-milling-dried-probiotics-material-and-cell-culture-media/ 2023-08-21T11:16:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bruker-continues-acquisition-spree-pheonomex/ 2023-08-31T10:44:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/exelixis-ipsen-approval-cabometyx-prostate-cancer/ 2023-08-30T14:47:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-eylea-hd-injection-fda/ 2023-08-21T10:29:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-orphan-status-alligator/ 2023-08-21T10:00:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-china-approval-forxiga/ 2023-08-21T08:21:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-tecvayli-multiple-myeloma/ 2023-08-29T04:10:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cancer-treatment-uncertainty-european-nations-struggle-with-drug-shortages/ 2023-08-28T14:24:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-win-migraine-prevention-drug-aquipta-europe/ 2023-08-18T17:04:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-ingelheim-weight-loss-drug-phase-iii-trials/ 2023-08-18T14:29:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/imugene-allogeneic-car-t-blood-cancer/ 2023-08-18T14:14:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abortion-pill-restriction-off-label-misoprostol/ 2023-08-30T12:30:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/coeptis-licenses-deverra-assets/ 2023-08-18T10:47:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bruker-cell-biology-company-phenomex/ 2023-08-23T10:43:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-competitive-intelligence-can-give-pharma-companies-an-edge/ 2023-08-24T10:29:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iveric-bio-maa-geographic-atrophy/ 2023-08-18T08:07:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nuvectis-cholangiocarcinoma-therapy/ 2023-08-18T08:51:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/landos-biopharma-gets-grant-for-compound-targeting-nlrx1-pathway-for-treating-various-diseases/ 2023-09-14T04:04:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/igm-biosciences-gets-grant-for-patent-granted-for-modified-antibodies-that-antagonize-t-cell-inhibitory-signaling/ 2023-09-12T05:25:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alx-oncology-gets-grant-for-a-polypeptide-that-targets-and-eliminates-cancer-cells/ 2023-09-12T05:26:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tigerconnect-gets-grant-for-system-for-sending-message-notifications-via-alternate-communications-method/ 2023-09-14T05:11:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/quantum-si-gets-grant-for-detection-of-single-molecules-using-labeled-nucleic-acid-linker/ 2023-09-14T05:12:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mersana-therapeutics-gets-grant-for-antibody-drug-conjugates-with-pyrrolo-2-1-c-1-4-benzodiazepine-drug-moieties/ 2023-09-13T12:07:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/a-menarini-industrie-farmaceutiche-riunite-gets-grant-for-cancer-stem-cell-targeted-cancer-vaccine-for-brain-cancer/ 2023-09-13T12:11:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yuhan-gets-grant-for-treatment-and-prevention-of-fap-mediated-diseases/ 2023-09-12T05:14:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biolinerx-gets-grant-for-the-patent-is-granted-for-a-method-of-treating-cancer/ 2023-09-14T04:19:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fibrogen-gets-grant-for-treating-anemia-in-kidney-disease-with-compound-formula-i/ 2023-09-13T12:22:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/marinus-pharmaceuticals-gets-grant-for-method-of-treating-status-epilepticus-with-ganaxolone-infusion/ 2023-09-13T12:26:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mochida-pharmaceutical-gets-grant-for-the-patent-is-granted-for-an-anti-presepsin-antibody/ 2023-09-14T04:28:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/active-biotech-gets-grant-for-treating-uveitis-with-periodic-administration-of-laquinimod/ 2023-09-12T05:19:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/redx-pharma-gets-grant-for-inhibitors-of-the-wnt-signalling-pathway-for-treating-various-cancers/ 2023-09-14T04:35:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jubilant-pharmova-gets-grant-for-patent-granted-for-liquid-oral-pharmaceutical-suspension-of-eslicarbazepine/ 2023-09-14T05:03:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/takara-gets-grant-for-method-for-producing-product-nucleic-acids-using-modified-oligonucleotides/ 2023-09-12T05:07:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mimedx-group-gets-grant-for-treating-cardiac-conditions-using-modified-placental-tissue/ 2023-09-12T05:09:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/valneva-gets-grant-for-cpg-adjuvanted-sars-cov-2-vaccine-composition-inducing-neutralizing-antibodies/ 2023-09-13T13:42:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aeterna-zentaris-gets-grant-for-method-for-diagnosing-and-treating-growth-hormone-deficiency-in-children/ 2023-09-13T13:49:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cassava-sciences-gets-grant-for-inhibiting-insulin-resistance-in-insulin-receptor-containing-cells/ 2023-09-12T05:13:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/esteve-pharmaceuticals-gets-grant-for-pharmacological-compounds-for-treating-drug-abuse-and-addiction/ 2023-09-12T04:53:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nippon-shinyaku-gets-grant-for-patent-granted-for-form-i-crystal-of-compound-a/ 2023-09-13T13:15:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xoma-gets-grant-for-combination-therapy-for-treating-cancer-using-tgf-and-pd-1-inhibitors/ 2023-09-13T13:17:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hansa-biopharma-gets-grant-for-patent-granted-for-a-polypeptide-with-igg-cysteine-protease-activity/ 2023-09-13T03:58:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dr-reddy-s-laboratories-gets-grant-for-crystalline-forms-of-a-3-substituted-1-2-4-oxadiazole-compound/ 2023-09-12T04:56:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/compugen-gets-grant-for-patent-granted-for-a-pharmaceutical-combination-with-ildr2-antagonist/ 2023-09-12T04:57:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dynavax-technologies-gets-grant-for-cpg-adjuvanted-sars-cov-2-vaccine-with-neutralizing-antibodies/ 2023-09-13T13:44:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/omeros-gets-grant-for-compound-with-masp-2-inhibitory-activity/ 2023-09-13T11:46:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ono-pharmaceutical-gets-grant-for-method-for-enhancing-immunity-against-solid-cancer-using-allergin-1-antagonist/ 2023-09-13T13:03:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gc-gets-grant-for-a-vaccine-composition-for-preventing-or-treating-chicken-pox-or-herpes-zoster/ 2023-09-12T12:08:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anavex-life-sciences-gets-grant-for-patent-granted-for-method-of-making-crystalline-forms-of-anavex2-73/ 2023-09-28T06:06:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xenon-pharmaceuticals-gets-grant-for-treatment-of-epilepsy-and-epileptic-seizure-disorders-using-benzenesulfonamide-compounds/ 2023-09-12T04:52:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lexicon-pharmaceuticals-gets-grant-for-treating-sars-cov-2-like-coronavirus-infection-with-a-specific-compound/ 2023-09-28T09:03:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eyepoint-pharmaceuticals-gets-grant-for-patent-granted-for-a-method-to-reduce-intraocular-pressure/ 2023-09-13T09:20:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/supernus-pharmaceuticals-gets-grant-for-treatment-of-aggression-impulsivity-and-irritability-using-molindone/ 2023-09-11T12:29:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intas-pharmaceuticals-gets-grant-for-extended-release-oral-pharmaceutical-composition-of-clozapine/ 2023-09-11T12:31:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anges-gets-grant-for-a-patent-granted-for-a-non-naturally-occurring-crispr-nuclease-composition/ 2023-09-13T09:25:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/charles-river-laboratories-international-gets-grant-for-method-for-producing-nucleic-acids-encoding-rabbit-human-hybrid-proteins/ 2023-09-11T13:09:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/humanigen-gets-grant-for-patent-granted-for-using-anti-hgm-csf-antibody-to-enhance-car-t-immunotherapy/ 2023-09-13T09:55:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/deciphera-pharmaceuticals-gets-grant-for-treating-tenosynovial-giant-cell-tumor-using-a-specific-compound/ 2023-09-13T12:20:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rigel-pharmaceuticals-gets-grant-for-imidazole-compounds-for-treating-tam-receptor-mediated-diseases/ 2023-09-13T08:30:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aim-immunotech-gets-grant-for-method-for-reducing-antigenic-drift-or-viral-reassortment-in-humans/ 2023-09-28T05:52:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/phio-pharmaceuticals-gets-grant-for-rnai-constructs-with-phosphorothioate-modified-nucleotides-for-gene-silencing/ 2023-09-07T07:45:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/macrogenics-gets-grant-for-patent-granted-for-a-da-cd3-binding-molecule-for-cancer-treatment/ 2023-09-07T07:46:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/revance-therapeutics-gets-grant-for-design-patent-for-a-graphical-user-interface-display-screen/ 2023-09-07T07:48:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/curis-gets-grant-for-treatment-of-phosphoinositide-3-kinase-related-diseases-and-disorders/ 2023-09-13T08:58:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/spectrum-pharmaceuticals-gets-grant-for-method-of-treating-neutropenia-with-modified-hg-csf-protein-complex/ 2023-09-28T06:03:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cara-therapeutics-gets-grant-for-the-patent-is-granted-for-a-formulation-of-a-therapeutic-agent/ 2023-09-07T07:51:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aurobindo-pharma-gets-grant-for-patent-granted-for-a-capsule-delivering-pimavanserin-for-parkinson-s-disease/ 2023-09-07T07:26:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hisamitsu-pharmaceutical-gets-grant-for-patent-granted-for-a-support-film-for-adhesive-tape/ 2023-09-12T10:07:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ocugen-gets-grant-for-method-for-treating-tissue-defects-using-a-double-structured-tissue-implant/ 2023-09-12T10:10:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vaccinex-gets-grant-for-combination-therapy-for-cancer-using-dendritic-cells-and-inhibitor/ 2023-09-07T07:35:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ac-immune-gets-grant-for-treatment-of-disorders-associated-with-tau-protein-aggregates/ 2023-09-12T10:13:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/altimmune-gets-grant-for-fluorocarbon-linked-immunogenic-peptides-in-solid-form/ 2023-09-12T10:19:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/les-laboratoires-servier-gets-grant-for-pharmaceutical-composition-comprising-palbociclib-tosylate-and-letrozole/ 2023-09-07T07:39:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/faes-farma-gets-grant-for-aqueous-pharmaceutical-composition-for-nasal-treatment-of-disorders/ 2023-09-12T10:23:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trevi-therapeutics-gets-grant-for-treating-idiopathic-pulmonary-fibrosis-ipf-cough/ 2023-09-07T07:40:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/haisco-pharmaceutical-group-gets-grant-for-implantable-annuloplasty-system-for-mitral-valve-repair/ 2023-09-07T07:43:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-appeals-court-favour-increasing-restrictions-abortion-pills/ 2023-08-18T14:23:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-pledges-210m-global-antimicrobial-resistance-surveillance/ 2023-08-17T15:19:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/briacell-nci-grant-cancer-platform/ 2023-08-17T10:18:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innovent-approval-china-nmpa-sintbilo/ 2023-08-17T10:20:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipsen-fibrodysplasia-ossificans-progressiva/ 2023-08-17T08:36:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/artiva-allonk-rituximab-sle-treatment/ 2023-08-17T06:55:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-will-not-meet-ahead-of-bluebird-bios-sickle-cell-disease-gene-therapy-pdufa-date/ 2024-08-28T13:04:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/diffusion-pharmas-stockholders-support-merger-with-eip-pharma/ 2023-08-16T15:43:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eyenovia-acquires-us-licencing-rights-for-formosas-topical-eye-steroid/ 2023-08-16T13:28:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amicus-gears-up-to-launch-pompe-disease-combination-therapy-in-the-uk/ 2023-08-16T13:11:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/galecto-terminates-development-for-its-lead-candidate/ 2023-08-16T12:51:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agc-asahi-substance-production/ 2023-08-16T10:30:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/precision-imugene-cancer-treatment-azer-cel/ 2023-08-16T10:28:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sectors/healthcare/leprosy-potentially-endemic-central-florida/ 2023-08-16T09:32:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-tentarix-cancer-inflammation-therapies/ 2023-08-16T09:11:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avidity-orphan-drug-designation-dmd/ 2023-08-16T09:04:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/robotics-transforming-cell-and-gene-therapy-manufacturing/ 2024-04-18T10:11:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/how-to-unlock-central-asias-potential-through-greenfield-investment/ 2023-08-15T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/insights/uk-inflation-rate-falls-again-but-why-is-it-still-so-high/ 2023-08-15T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-early-results-new-interleukin-targeting-antibody/ 2023-08-15T16:02:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/vwd-market-growth-increasing-recombinant-vwf/ 2023-08-15T15:44:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-delcath-therapy-metastatic-uveal-melanoma/ 2023-08-15T15:42:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/thermo-fisher-corevitas-acquisition/ 2023-08-15T14:36:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-elrexfio-janssen-rrmm-fda/ 2023-08-15T13:09:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-enter-eylea-biosimilar-race/ 2023-08-15T13:06:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-to-develop-a-flexible-packaging-approach-for-introducing-new-drugs-to-market-efficiently/ 2025-07-03T10:38:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/botulinum-battle-heats-up-with-fda-approving-daxxify-for-cervical-dystonia/ 2023-08-14T15:19:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lifearc-invests-nearly-10m-crick-institute-africa-scheme/ 2023-08-14T14:35:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valneva-pushes-fda-approval-date-chikungunya-vaccine/ 2023-08-14T14:03:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-acquires-chinook-boost-kidney-disease-pipeline/ 2023-08-14T13:50:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-the-pharma-industry-can-benefit-from-using-modular-real-time-technology/ 2023-08-14T14:48:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/rna-lnps-navigating-the-regulatory-challenges/ 2023-08-14T11:41:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/impact-pathologic-myopia-partnership/ 2023-08-14T10:30:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zetagen-series-b-round/ 2023-08-14T10:19:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vtv-fda-approval-cadisegliatin-type-1-diabetes/ 2023-08-14T13:21:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/democrats-new-legislation-inflation-reduction-act/ 2023-08-14T13:03:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hebecell-logomix-nk-cells/ 2023-08-16T15:41:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/akeega-fda-approval-janssens/ 2023-08-14T08:01:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/scotland-investment-foreign-fdi-hub-uk/ 2023-08-13T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genprex-reqorsa-orphan-drug-designation-fda-sclc/ 2023-08-11T15:26:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trisalus-merges-medtech-acquisition/ 2023-08-11T14:47:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxurion-unlocks-1m-atlas-diabetic-macular-oedema-therapy/ 2023-08-11T14:25:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/clinigen-divests-cancer-therapies/ 2023-08-11T13:50:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sutro-strengthens-its-immune-oncology-pipeline-with-two-new-adcs/ 2023-08-11T13:27:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wave-of-lay-offs-reveals-underlying-vulnerability/ 2023-08-29T10:22:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/absci-caltech-hiv-therapeutic-vaccine/ 2023-08-11T10:37:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/antengene-hansoh-xpovio-china/ 2023-08-11T10:40:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-astellas-snda-cresemba-aspergillosis/ 2023-08-11T08:37:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/city-of-hope-ovarian-cancer/ 2023-08-16T15:41:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/dentons-splits-from-its-china-unit-as-beijings-tightens-regulations/ 2023-08-10T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cd70-car-t-utc-therapeutics-anaplastic-large-cell-lymphoma-alcl-likelihood-of-approval/ 2025-01-19T18:27:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cd70-car-t-utc-therapeutics-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T18:27:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hrs-5965-jiangsu-hengrui-medicine-iga-nephropathy-berger-s-disease-likelihood-of-approval/ 2025-01-19T18:27:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/exo-cd24-what-is-the-likelihood-that-drug-will-be-approved/ 2023-08-10T17:27:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/my-008-createrna-science-and-technology-iga-nephropathy-berger-s-disease-likelihood-of-approval/ 2023-09-15T00:21:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bi-1823911-boehringer-ingelheim-international-metastatic-colorectal-cancer-likelihood-of-approval/ 2025-01-19T18:27:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mnv-201-what-is-the-likelihood-that-drug-will-be-approved/ 2023-08-10T17:27:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ath-1020-athira-pharma-neurodegenerative-diseases-likelihood-of-approval/ 2024-05-20T02:47:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gsk-3882347-what-is-the-likelihood-that-drug-will-be-approved/ 2023-08-10T17:25:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nvk-029-what-is-the-likelihood-that-drug-will-be-approved/ 2023-08-10T17:25:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ptg-007-poltreg-primary-progressive-multiple-sclerosis-ppms-likelihood-of-approval/ 2025-01-19T18:26:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/a-336-what-is-the-likelihood-that-drug-will-be-approved/ 2023-08-10T17:24:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nalmefene-what-is-the-likelihood-that-drug-will-be-approved/ 2023-08-10T17:24:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tn-201-tenaya-therapeutics-hypertrophic-cardiomyopathy-likelihood-of-approval/ 2024-09-09T02:26:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amg-119-amgen-small-cell-lung-cancer-likelihood-of-approval/ 2024-03-18T23:28:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/psilocybin-what-is-the-likelihood-that-drug-will-be-approved/ 2023-08-10T17:23:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hmbd-001-hummingbird-bioscience-pancreatic-ductal-adenocarcinoma-likelihood-of-approval/ 2025-01-19T18:26:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/vibozilimod-what-is-the-likelihood-that-drug-will-be-approved/ 2023-08-10T17:21:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kl-1333m-what-is-the-likelihood-that-drug-will-be-approved/ 2023-08-10T17:21:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zastaprazan-onconic-therapeutics-gastric-ulcers-likelihood-of-approval/ 2025-01-19T18:26:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/choh-01-cho-pharma-mantle-cell-lymphoma-likelihood-of-approval/ 2024-09-09T02:24:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/choh-01-cho-pharma-primary-mediastinal-b-cell-lymphoma-likelihood-of-approval/ 2024-09-09T02:24:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/choh-01-cho-pharma-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2024-09-09T02:24:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ebt-101-excision-biotherapeutics-human-immunodeficiency-virus-hiv-infections-aids-likelihood-of-approval/ 2024-04-19T17:01:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bepirovirsen-sodium-gsk-hepatitis-b-likelihood-of-approval/ 2025-01-19T18:26:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/asn-51-asceneuron-alzheimer-s-disease-likelihood-of-approval/ 2025-01-19T18:26:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/frexalimab-sanofi-relapsing-remitting-multiple-sclerosis-rrms-likelihood-of-approval/ 2025-01-19T16:36:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/frexalimab-sanofi-secondary-progressive-multiple-sclerosis-spms-likelihood-of-approval/ 2025-01-19T16:36:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iberdomide-hydrochloride-bristol-myers-squibb-refractory-multiple-myeloma-likelihood-of-approval/ 2025-01-19T18:25:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gedeptin-what-is-the-likelihood-that-drug-will-be-approved/ 2023-08-10T17:18:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apatinib-mesylate-elevar-therapeutics-gastroesophageal-ge-junction-carcinomas-likelihood-of-approval/ 2025-01-19T18:25:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/onabotulinumtoxin-a-abbvie-myofascial-pain-syndrome-chronic-myofascial-pain-likelihood-of-approval/ 2025-01-19T18:25:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rituximab-biosimilar-celltrion-primary-cns-lymphoma-likelihood-of-approval/ 2025-01-19T18:25:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iberdomide-hydrochloride-bristol-myers-squibb-relapsed-multiple-myeloma-likelihood-of-approval/ 2025-01-19T18:25:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tinostamustine-mundipharma-edo-t-cell-leukemia-likelihood-of-approval/ 2025-01-19T18:24:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bexotegrast-pliant-therapeutics-liver-fibrosis-likelihood-of-approval/ 2025-01-19T18:24:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oxu-001-what-is-the-likelihood-that-drug-will-be-approved/ 2023-08-10T17:16:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azacitidine-bristol-myers-squibb-pancreatic-ductal-adenocarcinoma-likelihood-of-approval/ 2025-01-19T18:25:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tucidinostat-huya-bioscience-international-anaplastic-large-cell-lymphoma-alcl-likelihood-of-approval/ 2025-01-19T18:25:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vemurafenib-f-hoffmann-la-roche-craniopharyngioma-likelihood-of-approval/ 2025-01-19T18:25:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fosravuconazole-what-is-the-likelihood-that-drug-will-be-approved/ 2023-08-10T17:16:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tara-002-protara-therapeutics-net-present-value/ 2024-06-13T18:49:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rmc-6236-revolution-medicines-net-present-value/ 2024-05-16T02:08:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/obicetrapib-newamsterdam-pharma-company-net-present-value/ 2024-12-13T02:53:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rz-402-rezolute-net-present-value/ 2024-09-08T18:18:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vafidemstat-oryzon-genomics-net-present-value/ 2024-12-13T02:51:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-1bn-acquire-inversago/ 2023-08-10T14:13:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-talvey-for-heavily-pre-treated-multiple-myeloma/ 2023-08-10T12:32:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/galera-lays-off-70-of-workforce-following-fda-rejection/ 2023-08-10T12:30:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ai-drug-discovery-development/ 2023-08-10T11:12:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genscript-t-maximum-car-t-cell-development/ 2023-08-10T10:49:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/palisade-bio-terminates-post-surgical-abdominal-adhesions-treatment-trial/ 2023-08-10T10:39:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adarx-clinical-programmes/ 2023-08-10T10:22:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-agreement-decibel-acquisition/ 2023-08-10T09:18:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teknova-facility-reagents/ 2023-08-16T15:41:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/patents/patent-activity-artificialintelligence-pharmaceutical-industry/ 2024-10-25T03:29:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/patents/patent-activity-covid-19-pharmaceutical-industry/ 2024-10-25T03:29:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/patents/patent-activity-futureofwork-pharmaceutical-industry/ 2024-10-25T03:29:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/patents/patent-activity-immuno-oncology-pharmaceutical-industry/ 2024-10-25T03:29:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/patents/patent-activity-microbiome-pharmaceutical-industry/ 2024-10-25T03:29:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/patents/patent-activity-pharmaceutical-industry/ 2024-10-25T05:32:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celmatix-and-ache-laboratorios-partner-to-tackle-unmet-need-for-pcos-drugs/ 2023-08-09T16:49:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sorrento-stock-sale-105m-recover-bankruptcy/ 2023-08-09T16:01:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/robotics-global-health-crisis/ 2023-08-09T14:42:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/daiichi-sankyo-fda-approval-vanflyta-aml/ 2023-08-14T18:29:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bactolife-raises-33m-develop-gut-microbiome-strengthening-proteins/ 2023-08-09T14:28:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agc-biologics-expands-viral-vector-manufacturing-capabilities-milan/ 2023-08-14T18:25:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/signal-kindeva-drug-delivery-having-very-good-week/ 2023-08-29T08:26:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-income-q2-2023/ 2023-08-09T10:56:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-fda-submission-chronic-hives-treatment/ 2023-08-09T13:44:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genscript-expands-peptides-zhenjiang/ 2023-08-09T10:41:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sk-bioscience-novavax/ 2023-08-09T08:38:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-astex-candidates-cancer/ 2023-08-09T07:22:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/from-europe-to-latin-america-driving-access-to-affordable-biosimilars/ 2023-08-28T16:42:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/whats-in-store-for-turkey-fdi-under-president-erdogan-2-0/ 2023-08-08T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/navigating-market-access-in-sweden/ 2024-01-29T16:53:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-invests-50m-in-poseidas-car-t-cell-therapy/ 2023-08-08T18:45:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-signs-stelara-biosimilar-settlement-deal-formycon-fresenius/ 2023-08-08T16:50:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arcus-gilead-terminate-development-etrumadenant-prostate-cancer/ 2023-08-08T16:47:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-positive-cardiovascular-profile-for-wegovy/ 2023-08-08T15:28:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jacobio-breakthrough-designation-glecirasib/ 2023-08-08T10:14:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/danam-merger-artemis/ 2023-08-08T10:57:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/artificial-intelligence-power-future-healthcare-provision/ 2023-08-08T09:35:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ginkgo-merck-biologic-manufacturing/ 2023-08-08T08:14:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-viatris-mapis-ga-depot/ 2023-08-08T07:54:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/signal-top-tweets-of-the-week-dissect-impact-of-obesity-drugs/ 2023-08-29T08:22:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/potential-treatment-inherited-blindness-wins-fda-fast-track/ 2023-08-10T16:00:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-duality-bio-investigational-drug-oncology-partnership/ 2023-08-07T15:06:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-releases-guidelines-minimise-cancer-causing-chemicals-drugs/ 2023-08-07T14:53:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-first-oral-treatment-postpartum-depression/ 2023-08-07T14:04:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-opens-vaccine-centre/ 2023-08-07T10:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/akeso-phase-iii-trials-ivonescimab-non-small-cell-lung-cancer/ 2023-08-07T13:30:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iveric-intravitreal-solution-fda/ 2023-08-07T10:28:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/canada-gsk-rsv-vaccine/ 2023-08-07T08:49:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/basilea-antibiotic-ceftobiprole/ 2023-08-07T08:52:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mesoblast-plans-new-gvhd-trial-after-another-fda-rejections/ 2023-08-04T15:42:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/evox-therapeutics-aav-development/ 2023-08-10T16:00:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/accord-commercialise-hipra-covid-19-vaccine-uk/ 2023-08-04T12:26:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-q2-2023/ 2023-08-04T10:54:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/bangladesh-dengue-vaccine/ 2023-08-04T15:50:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bluerock-bit-bio-t-cell-therapies/ 2023-08-09T12:09:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-next-privacy-battle-will-be-fought-over-health-data/ 2023-12-14T11:52:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-merck-ebola-vaccine/ 2023-08-04T07:38:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tweets-of-the-week-purdue-hiv-and-ai/ 2023-08-04T08:38:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ionis-novartis-cardiovascular-disease/ 2023-08-04T08:49:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/the-uk-national-security-act-nsi-carry-on-regardless-china/ 2023-08-03T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seattle-institute-lands-18m-funding-to-develop-rna-vaccine-for-chikungunya/ 2023-08-03T16:19:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kyverna-series-b-60m-car-ts-autoimmune-disorders/ 2023-08-10T16:00:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mithra-fuji-pharma-estelle-licence-payment/ 2023-08-03T16:01:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/generative-ai-revolutionise-drug-discovery/ 2023-08-28T15:41:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-grants-120m-contract-to-bavarian-nordic-for-smallpox-and-mpox-vaccines/ 2023-08-03T15:29:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/top-20-global-ma-legal-advisers-for-h1-2023-revealed/ 2023-08-03T14:59:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/top-20-global-ma-financial-advisers-for-h1-2023-revealed/ 2023-08-03T14:59:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/addex-wins-3m-to-research-substance-use-therapy/ 2023-08-03T15:15:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oramed-htit-joint-venture/ 2023-08-03T10:52:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/taiho-oncology-fda-approval-lonsurf/ 2023-08-03T09:06:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cg-oncology-funds/ 2023-08-03T07:51:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abm-orphan-drug-gbm-therapy/ 2023-08-03T09:05:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-cancer-drug-shortages-force-rationing-plans/ 2023-08-02T18:28:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deal-focus-biogens-gambit-to-boost-neurology-portfolio-with-reata-acquisition/ 2023-08-02T21:33:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aileron-therapeutics-files-patent-for-pharmaceutical-formulations-for-treating-diseases-using-peptidomimetic-macrocycles/ 2023-09-20T09:44:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acura-pharmaceuticals-files-patent-for-abuse-deterrent-pharmaceutical-composition-with-delayed-release-buffering/ 2023-08-18T11:03:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/towa-pharmaceutical-files-patent-for-the-patent-is-filed-for-a-composition-promoting-relaxation-and-sleep/ 2023-08-14T07:35:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/crinetics-pharmaceuticals-files-patent-for-parathyroid-hormone-receptor-modulator-compound/ 2023-08-14T07:38:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/syndax-pharmaceuticals-files-patent-for-combination-treatment-for-cancer-using-menin-and-cyp3a4-inhibitors/ 2023-08-18T11:15:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/can-fite-biopharma-files-patent-for-treatment-of-advanced-solid-tumors-using-an-a3ar-ligand/ 2023-08-14T08:07:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/applied-therapeutics-files-patent-for-methods-for-treating-genetic-and-metabolic-disorders-involving-sorbitol-metabolism/ 2023-08-14T08:15:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xenon-pharmaceuticals-files-patent-for-voltage-gated-sodium-channel-modulator-for-treating-seizure-disorders/ 2023-08-18T12:00:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/premier-files-patent-for-the-patent-filed-is-for-a-system-using-machine-learning-to-categorize-and-select-suggested-source-entities/ 2023-08-18T12:09:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ensysce-biosciences-files-patent-for-method-of-treating-viral-infection-with-nafamostat-mesylate-orally/ 2023-08-18T12:32:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/coherus-biosciences-files-patent-for-aseptic-packaging-method-for-sterile-pre-filled-injection-devices/ 2023-08-14T08:36:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/caribou-biosciences-files-patent-for-the-patent-is-filed-for-a-dual-guide-crispr-system/ 2023-08-14T08:49:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zydus-lifesciences-files-patent-for-treatment-for-primary-biliary-cholangitis-using-saroglitazar-magnesium-salt/ 2023-09-20T10:22:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/organovo-files-patent-for-bioprinted-three-dimensional-skin-tissues-and-methods-of-making-them/ 2023-09-20T10:28:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zhejiang-medicine-files-patent-for-method-for-preparing-nemonoxacin-malate-active-pharmaceutical-ingredient/ 2023-08-14T09:08:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intas-pharmaceuticals-files-patent-for-stable-extended-release-formulation-of-clozapine-with-improved-stability/ 2023-08-21T09:29:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aceragen-files-patent-for-treatment-of-farber-disease-using-purified-recombinant-human-acid-ceramidase/ 2023-08-14T09:18:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/verastem-files-patent-for-treating-cancer-with-a-mek-inhibitor-in-kras-g12v-mutation/ 2023-08-21T09:33:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atara-biotherapeutics-files-patent-for-method-for-treating-serous-ovarian-cancer-with-anti-activin-a-antibody/ 2023-08-14T09:16:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enzo-biochem-files-patent-for-compound-for-signal-amplification-and-detection-of-activators/ 2023-08-29T08:19:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cardiff-oncology-files-patent-for-method-for-treating-hematological-cancer-using-onvansertib-and-decitabine/ 2023-08-16T10:56:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/merus-files-patent-for-treatment-of-cancer-using-an-antibody-that-binds-lgr5-and-egfr/ 2023-08-16T11:01:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/karuna-therapeutics-files-patent-for-oral-pharmaceutical-composition-comprising-xanomeline-and-trospium-beads/ 2023-08-21T10:17:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innoviva-files-patent-for-compound-represented-by-structural-formula-a/ 2023-08-16T11:08:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/emergent-biosolutions-files-patent-for-the-patent-is-filed-for-a-stable-pharmaceutical-composition-with-naloxone/ 2023-08-21T10:24:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kaken-pharmaceutical-files-patent-for-pharmaceutical-formulation-for-external-application-with-low-viscosity-and-ph/ 2023-08-16T11:21:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biocon-files-patent-for-auto-injector-device-for-delivering-adjustable-volume-medicaments/ 2023-08-21T10:45:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aurinia-pharmaceuticals-files-patent-for-method-of-using-voclosporin-to-treat-or-prevent-coronavirus-infection/ 2023-08-21T10:48:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/viracta-therapeutics-files-patent-for-inhibitors-of-bruton-s-tyrosine-kinase-compound/ 2023-08-16T11:34:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sutro-biopharma-files-patent-for-stabilizing-freeze-dried-bacterial-extracts-for-protein-synthesis/ 2023-08-16T11:38:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fennec-pharmaceuticals-files-patent-for-pharmaceutical-composition-for-treating-ototoxicity-in-pediatric-patients/ 2023-08-21T11:00:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agenus-files-patent-for-antibodies-for-modulating-ox40-activity-in-treating-diseases/ 2023-08-21T11:05:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/quince-therapeutics-files-patent-for-inhibiting-the-lysine-gingipain-protease-from-porphyromonas-gingivalis/ 2023-08-21T11:19:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cidara-therapeutics-files-patent-for-treatment-of-bacterial-infections-using-conjugates-with-cyclic-heptapeptides/ 2023-08-22T09:52:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abivax-files-patent-for-treatment-or-prevention-of-coronaviridae-infection-in-humans/ 2023-08-17T05:38:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/first-wave-biopharma-files-patent-for-the-patent-is-filed-for-compounds-and-compositions-for-treating-coronavirus-infections/ 2023-09-21T10:06:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/faes-farma-files-patent-for-aqueous-pharmaceutical-composition-for-nasal-administration-with-bilastine/ 2023-08-22T10:03:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yunnan-baiyao-group-files-patent-for-antibacterial-and-antiviral-pharmaceutical-composition-using-specific-ingredients/ 2023-08-17T05:45:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/palatin-technologies-files-patent-for-treatment-of-sexual-dysfunction-in-females-with-controlled-hypertension/ 2023-08-22T11:49:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytokinetics-files-patent-for-treating-cachexia-syndrome-or-muscle-wasting-caused-by-various-conditions/ 2023-08-22T11:52:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iovance-biotherapeutics-files-patent-for-coordinating-manufacturing-of-expanded-t-cells-for-cancer-treatment/ 2023-08-22T12:15:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ocuphire-pharma-files-patent-for-synthesis-of-highly-pure-phentolamine-mesylate/ 2023-08-22T12:18:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amplia-therapeutics-files-patent-for-treating-or-preventing-pulmonary-fibrosis-using-a-fak-inhibitor/ 2023-08-17T05:58:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/betta-pharmaceuticals-files-patent-for-a-cancer-treatment-compound-and-its-pharmaceutical-composition/ 2023-08-22T12:37:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jounce-therapeutics-files-patent-for-treating-infectious-diseases-with-an-icos-agonist/ 2023-08-22T12:38:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/galecto-files-patent-for-process-for-preparing-a-compound-of-formula-x/ 2023-08-17T06:15:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acorda-therapeutics-files-patent-for-pharmaceutical-composition-for-sustained-release-oral-dosage-formulation/ 2023-08-22T12:43:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zhejiang-huahai-pharmaceutical-files-patent-for-an-isolated-antigen-binding-protein-for-preventing-or-treating-tigit-related-diseases/ 2023-08-17T06:22:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aquestive-therapeutics-files-patent-for-oral-film-for-controlled-delivery-of-actives/ 2023-09-12T06:22:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adc-therapeutics-files-patent-for-antibody-drug-conjugate-for-prostate-specific-membrane-antigen-psma/ 2023-08-17T06:28:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eisai-files-patent-for-therapeutic-agent-for-fatty-liver-diseases/ 2023-08-17T06:29:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/geron-files-patent-for-preparation-of-amorphous-solid-composition-of-fatty-acid-metal-salt/ 2023-08-22T12:54:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/phasebio-pharmaceuticals-files-patent-for-modeling-dosing-regimen-of-an-antibody-for-platelet-aggregation/ 2023-08-17T06:32:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acadia-pharmaceuticals-files-patent-for-stable-intranasal-pharmaceutical-preparation-for-carbetocin-treatment/ 2023-09-20T10:34:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/emcure-pharmaceuticals-files-patent-for-ready-to-use-solution-of-carmustine-for-parenteral-administration/ 2023-08-22T13:01:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biophytis-files-patent-for-a-composition-for-preventing-muscle-strength-loss-during-immobilization/ 2023-08-23T09:20:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/athersys-files-patent-for-treating-viral-induced-ards-with-non-embryonic-stem-cells/ 2023-08-23T09:26:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orgenesis-files-patent-for-treatment-for-viral-diseases-using-ribonucleases-and-bioxomes-exosomes/ 2023-08-17T07:37:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arbutus-biopharma-files-patent-for-nucleic-acid-based-therapy-compositions-and-methods/ 2023-08-17T06:46:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cassava-sciences-files-patent-for-biomarker-panel-for-diagnosing-and-treating-neurocognitive-disorders/ 2023-08-23T09:17:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/athenex-files-patent-for-pharmaceutical-combination-for-treating-angiosarcoma-with-oral-paclitaxel/ 2023-08-23T09:45:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/diffusion-pharmaceuticals-files-patent-for-treatment-of-viral-or-bacterial-respiratory-disease-with-hypoxemia/ 2023-08-17T08:00:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glycomimetics-files-patent-for-cd33-ligands-for-cd33-ligand-bearing-carriers-with-anti-cancer-agents/ 2023-08-17T08:03:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mimedx-group-files-patent-for-method-for-preparing-placenta-membrane-tissue-grafts/ 2023-08-23T10:06:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dr-reddy-s-laboratories-files-patent-for-pharmaceutical-composition-for-treating-cancer/ 2023-08-23T10:13:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shin-poong-pharm-files-patent-for-use-of-pyronaridine-or-artemisinin-for-treating-covid-19/ 2023-09-21T10:13:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/otonomy-files-patent-for-otic-formulation-for-sustained-release-of-growth-factor-in-ear/ 2023-08-23T10:23:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vyne-therapeutics-files-patent-for-the-patent-is-filed-for-a-liquisoft-complex-composition-for-treating-skin-disorders/ 2023-08-17T08:19:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/curevac-files-patent-for-rna-vaccine-combined-with-pd-1-pathway-inhibitor-for-disease-treatment/ 2023-08-17T08:23:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zymeworks-files-patent-for-masked-il12-fusion-protein-for-treating-diseases-including-cancer/ 2023-08-17T08:25:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/top-20-global-ma-financial-advisers-for-h1-2023-revealed-2/ 2023-08-02T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/top-20-global-ma-legal-advisers-for-h1-2023-revealed-2/ 2023-08-02T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cs-pharmaceuticals-snaps-up-axerovision-to-shore-up-ophthalmology-portfolio/ 2023-08-02T15:34:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/atantares-13-9m-pre-series-a-funding-develop-molecular-chips/ 2023-08-02T15:42:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-warns-reduced-efficacy-oral-birth-control-pill-tydemy/ 2023-08-02T14:51:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/top-10-ma-legal-advisers-h1-2023-north-america/ 2023-08-04T14:19:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/top-10-ma-financial-advisers-h1-2023-north-america/ 2023-08-04T14:19:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amygdala-scores-2m-niaaa-grant-develop-alcohol-use-disorder-therapy/ 2023-08-02T14:06:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-risks-of-endotoxins-in-water-systems-where-they-arise-and-how-to-respond/ 2023-08-02T13:45:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-q2-reported-net-income/ 2023-08-02T10:11:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tyra-fda-achondroplasia/ 2023-08-02T10:17:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/promising-pharma-earnings-despite-covid-losses/ 2023-08-29T08:17:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ubc-oracle-cloud-technology/ 2023-08-02T08:54:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/revolution-medicines-eqrx/ 2023-08-02T08:48:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/top-10-ma-legal-advisers-h1-2023-north-america-2/ 2023-08-01T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/top-10-ma-financial-advisers-h1-2023-north-america-2/ 2023-08-01T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/neuraxpham-gears-up-to-market-tgs-relapsing-ms-treatment-briumvi-in-europe/ 2023-08-01T19:00:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/puretech-potential-treatment-fxtas/ 2023-08-02T10:03:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/nash-market-holds-untapped-potential/ 2023-08-01T16:28:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-tracks-invectys-car-t-therapy-renal-cell-carcinoma/ 2023-08-02T10:24:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/renaissance-in-license-humanised-antibody/ 2023-08-01T15:14:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emergent-secures-704m-contract-for-ebola-treatment-ebanga/ 2023-08-01T14:19:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-arvinas-win-uk-fast-track-tag-breast-cancer-drug/ 2023-08-01T14:18:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sectors/healthcare/cyltezo-biosimilar-market/ 2023-08-01T11:43:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nmpa-astellas-zolbetuximab-bla/ 2023-08-01T10:26:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-fda-endometrial-cancer/ 2023-08-01T09:25:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-acquires-instadeep/ 2023-08-01T08:48:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-ztalmy-seizures-cdkl5/ 2023-08-01T07:47:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/italy-m-a-activity-pharmaceutical-industry/ 2024-12-02T16:27:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/germany-m-a-activity-pharmaceutical-industry/ 2024-02-16T01:48:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/germany-privateequity-activity-pharmaceutical-industry/ 2024-09-10T02:25:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/china-privateequity-activity-pharmaceutical-industry/ 2024-02-16T01:51:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/privateequity-activity-immuno-oncology-pharmaceutical-industry/ 2023-10-26T00:44:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/ma-activity-big-data-pharmaceutical-industry/ 2024-12-02T16:38:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/ma-activity-regenerative-medicine-pharmaceutical-industry/ 2024-12-02T16:27:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/german-companies-in-hungary-now-face-hostile-takeovers-from-the-orban-government/ 2023-07-31T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/uk-inward-investment-regional-competitiveness-index-fdi/ 2023-07-31T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/non-profit-receives-fda-approval-to-supply-cheaper-otc-naloxone/ 2023-07-31T18:14:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/searchlight-mithra-menopause-drug-donesta/ 2023-07-31T15:52:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/santhera-divests-rare-eye-disease-drug-raxone-chiesi/ 2023-07-31T15:30:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/type-1-diabetes-treatment-medicine/ 2023-07-31T15:29:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/asimov-hippocratic-oath-ai-healthcare/ 2023-07-31T15:21:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/mrna-cancer-vaccines-comparisons/ 2023-08-02T14:01:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/top-10-ma-legal-advisers-h1-2023-europe/ 2023-08-04T14:47:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/top-10-ma-financial-advisers-h1-2023-europe/ 2023-08-04T14:40:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gene-therapy-manufacture-robotics/ 2023-07-31T14:19:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hepatitis-b-global-market-treatments/ 2023-07-31T14:07:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-ind-application-leads-bispecific-antibody/ 2023-07-31T15:22:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lupin-recalls-tydemy/ 2023-07-31T10:31:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daewoong-china-fexuprazan/ 2023-07-31T10:47:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alexion-pfizer-gene-therapies/ 2023-07-31T09:45:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-agreement-acquire-reata/ 2023-07-31T08:51:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jobs-signal-us-continues-to-top-destination-for-pharma-jobs-in-recent-months/ 2023-07-31T12:17:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/rx-machina-how-ai-is-transforming-pharma-sales/ 2023-07-31T02:29:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cap-1002-nippon-shinyaku-net-present-value/ 2024-12-13T02:50:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bgb-3245-springworks-therapeutics-net-present-value/ 2024-05-16T02:07:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cemiplimab-regeneron-pharmaceuticals-natural-killer-cell-lymphomas-likelihood-of-approval/ 2025-01-19T18:22:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cemiplimab-regeneron-pharmaceuticals-t-cell-lymphomas-likelihood-of-approval/ 2025-01-19T18:22:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rademikibart-suzhou-connect-biopharmaceuticals-asthma-likelihood-of-approval/ 2025-01-19T18:22:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bnt-111-biontech-melanoma-likelihood-of-approval/ 2024-05-20T02:40:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dexamethasone-sodium-phosphate-sr-taiwan-liposome-osteoarthritis-pain-likelihood-of-approval/ 2023-07-31T17:41:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ropanicant-suven-life-sciences-major-depressive-disorder-likelihood-of-approval/ 2023-07-31T17:40:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/paxalisib-kazia-therapeutics-leptomeningeal-disease-neoplastic-meningitis-leptomeningeal-carcinomatosis-likelihood-of-approval/ 2025-01-19T18:21:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glufosfamide-eleison-pharmaceuticals-metastatic-adenocarcinoma-of-the-pancreas-likelihood-of-approval/ 2023-07-31T17:38:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pv-001-posvax-human-papillomavirus-infections-likelihood-of-approval/ 2023-07-31T17:35:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/si-101-sirpant-immunotherapeutics-non-hodgkin-lymphoma-likelihood-of-approval/ 2024-09-09T02:22:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/esk-001-alumis-systemic-lupus-erythematosus-likelihood-of-approval/ 2025-01-19T18:24:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/domiphen-bromide-miconazole-female-healthcare-purna-vulvovaginal-candidiasis-likelihood-of-approval/ 2023-07-31T17:34:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/povetacicept-alpine-immune-sciences-idiopathic-thrombocytopenic-purpura-immune-thrombocytopenic-purpura-likelihood-of-approval/ 2025-01-19T18:24:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sph-4336-shanghai-pharmaceutical-group-dedifferentiated-liposarcoma-likelihood-of-approval/ 2025-01-19T18:24:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cd19-cd22-car-t-shanghai-unicar-therapy-bio-medicine-technology-mantle-cell-lymphoma-likelihood-of-approval/ 2025-01-19T18:23:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cd19-cd22-car-t-shanghai-unicar-therapy-bio-medicine-technology-follicular-lymphoma-likelihood-of-approval/ 2025-01-19T18:23:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cd19-cd22-car-t-shanghai-unicar-therapy-bio-medicine-technology-b-cell-non-hodgkin-lymphoma-likelihood-of-approval/ 2025-01-19T18:23:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cd19-cd22-car-t-shanghai-unicar-therapy-bio-medicine-technology-primary-mediastinal-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T18:23:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nitronazine-guangzhou-magpie-pharmaceutical-acute-ischemic-stroke-likelihood-of-approval/ 2024-06-14T03:55:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/salutaxel-shenzhen-salubris-pharmaceuticals-breast-cancer-likelihood-of-approval/ 2024-07-05T06:03:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cd19-cd22-car-t-shanghai-unicar-therapy-bio-medicine-technology-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T18:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/icg-122-icell-gene-therapeutics-t-cell-lymphomas-likelihood-of-approval/ 2024-07-05T06:02:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dordaviprone-chimerix-net-present-value/ 2024-06-13T18:53:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/top-10-ma-legal-advisers-h1-2023-europe-2/ 2023-07-30T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/top-10-ma-financial-advisers-h1-2023-europe-2/ 2023-07-30T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/brics-future-alternative-china-brazil-russia-india-southafrica/ 2023-07-30T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ns-pharma-scores-breakthrough-therapy-status-for-dmd-therapy/ 2023-07-28T17:23:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inflationary-pressure-drop-contract-manufacturing-ma/ 2023-07-28T14:37:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sanders-drug-price-caps/ 2023-07-28T12:09:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/carmell-regenerative-medicine-axolotl/ 2023-07-28T10:30:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bristol-myers-squibb-q2-2023/ 2023-07-28T10:28:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/insilicotrials-axoltis-neurological-disorders/ 2023-07-28T09:38:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-metastatic-breast-cancer-drug-trodelvy/ 2023-07-28T08:22:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/hiring-asia-pacific-pharma-industry/ 2024-07-19T04:12:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/hiring-chinese-pharma-industry/ 2024-07-19T04:12:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/hiring-indian-pharma-industry/ 2023-10-19T17:10:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/hiring-japanese-pharma-industry/ 2023-10-19T17:11:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/hiring-swiss-pharma-industry/ 2023-10-19T17:11:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/cellgenetherapy-hiring-pharmaceutical-industry/ 2024-08-22T12:49:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/precisionandpersonalizedmedicine-hiring-pharmaceutical-industry/ 2024-08-22T12:45:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/artificialintelligence-hiring-pharmaceutical-industry/ 2024-08-22T12:49:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/cloud-hiring-pharmaceutical-industry/ 2024-08-22T12:49:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/corporategovernance-hiring-pharmaceutical-industry/ 2024-08-22T12:49:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/cybersecurity-hiring-pharmaceutical-industry/ 2024-08-22T12:49:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/france-privateequity-activity-pharmaceutical-industry/ 2024-05-21T02:35:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/australia-m-a-activity-pharmaceutical-industry/ 2024-12-02T16:27:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/brazil-m-a-activity-pharmaceutical-industry/ 2024-02-16T01:51:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/singapore-m-a-activity-pharmaceutical-industry/ 2024-12-02T16:27:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/france-m-a-activity-pharmaceutical-industry/ 2024-05-21T02:34:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/canada-m-a-activity-pharmaceutical-industry/ 2024-12-02T16:27:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/ma-activity-social-responsibility-pharmaceutical-industry/ 2024-12-02T16:37:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/ma-activity-covid-19-pharmaceutical-industry/ 2024-12-02T16:37:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/privateequity-activity-smart-hospitals-pharmaceutical-industry/ 2024-11-08T03:43:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/ma-activity-artificial-intelligence-pharmaceutical-industry/ 2024-12-02T16:37:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/ma-activity-smart-hospitals-pharmaceutical-industry/ 2024-12-02T16:38:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/ma-activity-precision-and-personalized-medicine-pharmaceutical-industry/ 2024-12-02T16:27:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/ma-activity-digitalization-pharmaceutical-industry/ 2024-12-02T16:38:08+00:00 daily 0.2